<SEC-DOCUMENT>0001178913-16-007016.txt : 20161123
<SEC-HEADER>0001178913-16-007016.hdr.sgml : 20161123
<ACCEPTANCE-DATETIME>20161123105623
ACCESSION NUMBER:		0001178913-16-007016
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20161123
FILED AS OF DATE:		20161123
DATE AS OF CHANGE:		20161123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36848
		FILM NUMBER:		162015338

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			30090
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			30090
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk1619227.htm
<DESCRIPTION>6-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br>
<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">UNITED STATES</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">WASHINGTON, DC 20549</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">FORM 6-K</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">REPORT OF FOREIGN PRIVATE ISSUER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-STYLE: normal; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold">PURSUANT </font><font style="FONT-WEIGHT: bold">TO</font>&#160;<font style="FONT-WEIGHT: bold">RULE 13a-16 OR 15d-16 </font><font style="FONT-WEIGHT: bold">UNDER</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">For</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> November 2016</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: center; FONT: bold 10pt/1.25 'Times New Roman', Times, serif">Commission File No. 001-36848</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 16pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal">Check-Cap Ltd. </font>

<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Check-Cap Building</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Abba Hushi Avenue</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">P.O. Box 1271</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Isfiya, 30090</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Mount Carmel, Israel</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 155pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Form 20-F &#9746;&#160;&#160;&#160;&#160; Form 40-F &#9744;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 175pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes&#160;&#9744;&#160;&#160;&#160; No &#9746;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">If &#8220;Yes&#8221; marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-___</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Form 6-K is being incorporated by reference into the Post-Effective Amendment No. 1 to the Form S-8 Registration Statement File No. 333-203384 and into the Form F-3 Registration Statement File No. 333-211065.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div>
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Other Information</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Attached hereto as Exhibit 99.1 is a Notice of 2016 Annual General Meeting of Shareholders (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Annual</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Meeting</font>&#8221;) and the Proxy Statement of Check-Cap Ltd. (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Company</font>&#8221;) relating to the Company&#8217;s Annual Meeting. In addition, a copy of the Proxy Card is attached hereto as Exhibit 99.2.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Where to Find Additional Information</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Shareholders are urged to carefully read the Proxy Statement, because it contains important information about the Company and the Annual Meeting. Copies of the Proxy Statement and other documents filed by the Company will be available at the website maintained by the Securities and Exchange Commission at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>www.sec.gov</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Exhibits</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z985238a986b648d58938f56dddf35c5d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 11%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exhibit No.</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 11%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">99.1</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Notice and the Proxy Statement for the 2016 Annual General Meeting of Shareholders to be held on December 22, 2016.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 11%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">99.2</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 87%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Form of Proxy Card.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SIGNATURE</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Pursuant to the requirements of the&#160;Securities&#160;Exchange Act of 1934, the&#160;registrant&#160;has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z2a629d6228a746b89aa1220ba9ef8929" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: separate; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 38%" valign="top" colspan="2"><strong>Check-Cap Ltd.</strong></td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="PADDING-BOTTOM: 2px; WIDTH: 50%" valign="top" align="left"></td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 3%" valign="top">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">By: </div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 35%" valign="top" nowrap="nowrap" align="left">/s/&#160;Lior Torem</td>
<td style="PADDING-BOTTOM: 2px; WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="bottom" nowrap="nowrap" align="left">Name: Lior Torem</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">Title: Chief Financial Officer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%" valign="top">&#160;</td>
<td style="WIDTH: 3%" valign="top">&#160;</td>
<td style="WIDTH: 35%" valign="top">&#160;</td>
<td style="WIDTH: 12%" valign="top">&#160;</td>
</tr>
</table>

Dated: November 23, 2016</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div>&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>PROXY STATEMENT
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center">
<br>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><u>Exhibit 99.1</u></font><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><img style="WIDTH: 122px; HEIGHT: 51px" src="image0.jpg"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 414pt; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; November 23, 2016</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Dear Shareholder,</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">You are cordially invited to attend the 2016 Annual General Meeting of Shareholders (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Meeting</font>&#8221;) of Check-Cap Ltd. (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Company</font>&#8221;), to be held on Thursday, December 22, 2016, at 4:00 p.m. (Israel time) at the Company&#8217;s offices at the Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The Notice of 2016 Annual General Meeting of Shareholders and the Proxy Statement appearing on the following pages describe in detail the matters to be considered and acted upon at the Meeting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Only shareholders who held shares at the close of business on November 21, 2016, are entitled to notice of, and to vote at, the Meeting and any adjournments thereof. The Company&#8217;s Board of Directors recommends a vote &#8220;FOR&#8221; each of the proposals set forth in the Proxy Statement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Whether or not you plan to attend the Meeting, it is important that your shares be represented and voted at the Meeting.&#160; Accordingly, after reading the enclosed Notice of 2016 Annual General Meeting of Shareholders and accompanying Proxy Statement, please sign, date and mail the enclosed proxy card in the envelope provided in accordance with the instructions in the Proxy Statement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We look forward to seeing as many of you as can attend the Meeting.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z5f49753f23cc46a896b0801df03a0a3c" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="WIDTH: 50%; FONT-FAMILY: 'Times New Roman', Times, serif">
<div>Very truly yours,</div>

<div>&#160;</div>

<div style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><u>/s/ Tomer Kariv</u></div>

<div>Tomer Kariv</div>

<div>Chairman of the Board of Directors</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><img style="WIDTH: 114px; HEIGHT: 38px" src="image0.jpg"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Check-Cap Ltd.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Check-Cap Building</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Abba Hushi Avenue</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">P.O. Box 1271</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Isfiya, 30090</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Mount Carmel, Israel</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTICE OF 2016 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Dear Shareholder:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We cordially invite you to attend the 2016 Annual General Meeting of Shareholders of Check-Cap Ltd. (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Meeting</font>&#8221;) to be held on Thursday, December 22, 2016, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel, for the following purposes:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zab10df4f8ffb4e37bf01f7a2b83e67fd" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To re-elect five directors to serve as members of our Board of Directors (in addition to the two external directors under Israeli law), until our next annual general meeting of shareholders;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z20415091480e40e087a8ff6595d5110b" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To approve the compensation to be paid to each of the non-employee directors (other than the Chairman of the Board of Directors and the external directors under Israeli law), subject to their election at the Meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z3d3a29a99cdb4dd39703e48a4dad4f73" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To ratify and approve the reappointment of Brightman Almagor Zohar &amp; Co., a member of Deloitte Touche Tohmatsu, as our independent auditor for the year ending December 31, 2016 and for such additional period until our next annual general meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z9cdc0557725e47ff8febfa57271182df" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To approve the payment to our Chief Executive Officer of the discretionary component of the pro-rated annual bonus for the year ended December 31, 2015;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zd1707215601048258b9dfd82d6ab84d7" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To approve the payment to our Chief Technology Officer (who served as a director until December 2015) of the discretionary component of the annual bonus for the year ended December 31, 2015; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zbec522fce5dc4bfaadd312992e58a508" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">6.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">To review and discuss our financial statements for the year ended December 31, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are currently not aware of any other matters that will come before the Meeting. If any other matters are presented properly at the Meeting, the persons designated as proxies intend to vote upon such matters in accordance with their best judgment.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Only shareholders of record at the close of business on November 21, 2016, are entitled to notice of and to vote at the Meeting or at any adjournment thereof.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The Proxy Statement describing the various matters to be voted upon at the Meeting and the accompanying proxy card will be mailed to such shareholders on or about November 23, 2016.&#160; Shareholders may review the full version of the proposed resolutions in the Proxy Statement as well as the accompanying proxy card, on, or about, November 23, 2016, via the website of the U.S. Securities and Exchange Commission at<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>&#160;</u></font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>www.sec.gov</u></font> as well as under the Investors section of our website at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>http://ir.check-cap.com</u></font>, and also at our offices during regular business hours (Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel; Tel: +972-4-8303400 (phone)).</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber"></font>&#160;</div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Proxies must be received by our transfer agent or at our registered office in Israel no later than forty eight (48) hours prior to the designated time for the Meeting.&#160; Proxies received by our transfer agent or at our registered office in Israel during the forty eight (48) hours preceding the designated time for the Meeting will be presented to the Chairman of the Meeting and, at his discretion, may be voted as specified in the instructions included in such proxies.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our company&#8217;s representatives are Lior Torem, our Chief Financial Officer, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>liort@check-cap.com</u></font><font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</font>or +972-4-8303401, and Dana Zigman-Behrend, our General Counsel, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>dana.behrend@check-cap.com</u></font> or +972-4-8303424, Check-Cap Ltd., Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel; Tel: +972-4-8303424.&#160; Detailed voting instructions are provided both in the Proxy Statement and the proxy card.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quorum</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The presence, in person or by proxy, of two or more shareholders holding or representing, in the aggregate, at least twenty-five percent (25%) of our company&#8217;s voting rights will constitute a quorum at the Meeting.&#160; No business will be considered or determined at the Meeting unless the requisite quorum is present within half an hour from the time designated for the Meeting.&#160; If within half an hour from the time designated for the Meeting a quorum is not present, the Meeting will stand adjourned to the same day in the following week, at the same time and place.&#160; At least two shareholders present, in person or by proxy, will constitute a quorum at the adjourned meeting.&#160; This notice will serve as notice of such reconvened meeting if no quorum is present at the original date and time and no further notice of the reconvened meeting will be given to shareholders.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Vote Required for Approval of the Proposals</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Each ordinary share entitles the holder to one vote.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to approve each of the proposals.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In addition, for the approval of Proposal 4, one of the following two voting requirements must be met: (i) at least a majority of the shares held by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter, present in person or by proxy and voting on the matter at the Meeting (excluding abstentions), voted in favor of the proposal, or (ii) the total number of shares voted against the proposal by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter, does not exceed two-percent (2%) of our outstanding voting rights.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are unaware of any shareholder that would be deemed to be a controlling shareholder of our company as of the current time for purposes of Proposal 4.&#160; A shareholder who signs and returns a proxy card will be deemed to be confirming that such shareholder, and any related party of such shareholder, is not a controlling shareholder for purposes of Proposal 4.&#160; If you believe that you, or a related party of yours, may be deemed to be a controlling shareholder and you wish to participate in the vote on Proposal 4, you should contact our Chief Financial Officer, Lior Torem, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>liort@check-cap.com</u></font><font style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</font>or +972-4-8303401 or Dana Zigman-Behrend, General Counsel, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>dana.behrend@check-cap.com</u></font> or +972-4-8303424.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The Israeli Companies Law, 1999 (the &#8220;Israeli Companies Law&#8221;) requires that each shareholder voting on Proposal 4 indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at the Meeting, whether or not the shareholder has a personal interest in such proposal.&#160; Otherwise, the shareholder is not eligible to vote on the proposal and his or her vote will not be counted for the purposes of the proposal.&#160; Under the Israeli Companies Law, a &#8220;personal interest&#8221; of a shareholder in an act or transaction of a company (i) includes a personal interest of (a) any spouse, sibling, parent, grandparent or descendant of the shareholder, any descendant, sibling or parent of a spouse of the shareholder and the spouse of any of the foregoing; and (b) a company with respect to which the shareholder (or any of the foregoing relatives of the shareholder) owns at least 5% of the outstanding shares or voting rights, serves as a director or chief executive officer or has the right to appoint one or more directors or the chief executive officer; and (ii) excludes a personal interest arising solely from the ownership of shares.&#160; Under the Israeli Companies Law, in the case of a person voting by proxy, &#8220;personal interest&#8221; includes the personal interest of either the proxy holder or the shareholder granting the proxy, whether or not the proxy holder has discretion how to vote.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="ze6703fa98b8243658e21a315e4263572" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="WIDTH: 50%; FONT-FAMILY: 'Times New Roman', Times, serif">
<div>
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Sincerely,</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>
</div>

<div style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><u>/s/ Tomer Kariv</u></div>

<div>&#160;</div>

<div>Tomer Kariv</div>

<div style="FONT-STYLE: italic">Chairman of the Board of Directors</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">November 23, 2016</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">ii</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Check-Cap Ltd.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Check-Cap Building</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Abba Hushi Avenue</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">P.O. Box 1271</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Isfiya, 30090</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Mount Carmel, Israel</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">_____________________</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROXY STATEMENT</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2016 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">This Proxy Statement is being furnished in connection with the solicitation of proxies on behalf of the Board of Directors of Check-Cap Ltd. to be voted at the 2016 Annual General Meeting of Shareholders (the &#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Meeting</font>&#8221;), and at any adjournment thereof, pursuant to the accompanying Notice of 2016 Annual General Meeting of Shareholders.&#160; The Meeting will be held on Thursday, December 22, 2016, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">This Proxy Statement, the attached Notice of the Meeting and the enclosed proxy card are being mailed to shareholders on or about November 21, 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Purpose of the Annual General Meeting</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">At the Meeting, shareholders will be asked to consider and vote upon the following:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z5d0f610d59a8471f99e3f097982b4f19" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The re-election of five directors to serve as members of our Board of Directors (in addition to the two external directors under Israeli law), until our next annual general meeting of shareholders;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zca2f658bf586480b86ac49e7dd0b4d42" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The approval of the compensation to be paid to each of the non-employee directors (other than the Chairman of the Board of Directors and the external directors under Israeli law), subject to their election at the Meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z37872907d0f34e54b19738b988d1a687" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The ratification and approval of the reappointment of Brightman Almagor Zohar &amp; Co., a member of Deloitte Touche Tohmatsu, as our independent auditor for the year ending December 31, 2016 and for such additional period until our next annual general meeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z7449e719bd9b4a23ae9cb90b435dcf0e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The approval of the payment to our Chief Executive Officer of the discretionary component of the pro-rated annual bonus for the year ended December 31, 2015; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z6b79e55fb6634b5c859fd042d028292f" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The approval of the payment to our Chief Technology Officer (who served as a director until December 2015) of the discretionary component of the annual bonus for the year ended December 31, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In addition, our financial statements for the year ended December 31, 2015 will be reviewed and discussed at the Meeting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are not aware of any other matters that will come before the Meeting.&#160; If any other matters properly come before the Meeting, the persons designated as proxies intend to vote on such matters in accordance with the judgment and recommendation of the Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recommendation of the Board of Directors</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Board of Directors recommends a vote FOR each of the proposals set forth in this Proxy Statement.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Who Can Vote</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">You are entitled to notice of, and to vote in person or by proxy at, the Meeting, if you are a holder of record of our ordinary shares as of the close of business on November 21, 2016.&#160; You are also entitled to notice of the Meeting and to vote at the Meeting if you held ordinary shares through a bank, broker or other nominee that is one of our shareholders of record at the close of business on November 21, 2016, or which appeared in the participant listing of a securities depository on that date.&#160; See below &#8220;How You Can Vote.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">How You Can Vote</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z5bb51fd1146d433a8b916e75eff018cc" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Voting in Person</font>.&#160; If you are a shareholder of record, i.e., your shares are registered directly in your name with our transfer agent, American Stock Transfer &amp; Trust Company LLC, you may attend and vote in person at the Meeting.&#160; If you are a beneficial owner of shares registered in the name of your broker, bank, trustee or nominee (i.e., your shares are held in &#8220;street name&#8221;), you are also invited to attend the Meeting; however, to vote in person at the Meeting as a beneficial owner, you must first obtain a &#8220;legal proxy&#8221; from your broker, bank, trustee or nominee that holds your shares giving you the right to vote the shares at the Meeting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z09dce6e71aaf4f1193c5a1832350b0c8" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Voting by Proxy</font>.&#160; If you are a shareholder of record, these proxy materials are being sent directly to you by our transfer agent. You may submit your proxy by completing, signing and mailing the enclosed proxy card that was mailed to you in the enclosed, postage-paid envelope.&#160; If your ordinary shares are held in &#8220;street name,&#8221; these proxy materials are being forwarded to you by the broker, trustee or nominee or an agent hired by the broker, trustee or nominee.&#160; Please follow the voting instructions provided to you by your broker, trustee or nominee.&#160; Proxies must be received by our transfer agent or at our registered office in Israel no later than forty eight (48) hours prior to the designated time for the Meeting. Proxies received by our transfer agent or at our registered office in Israel during the forty eight (48) hours preceding the designated time for the Meeting will be presented to the Chairman of the Meeting and, at his discretion, may be voted as specified in the instructions included in such proxies.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Change or Revocation of Proxy</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">If you are a shareholder of record, you may change your vote at any time prior to the exercise of authority granted in the proxy by delivering a written notice of revocation to our Chief Financial Officer or General Counsel, by granting a new proxy bearing a later date, or by attending the Meeting and voting in person.&#160; Attendance at the Meeting will not cause your previously granted proxy to be revoked unless you specifically so request.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">If your shares are held in &#8220;street name,&#8221; you may change your vote by submitting new voting instructions to your broker, bank, trustee or nominee or, if you have obtained a legal proxy from your broker, bank, trustee or nominee giving you the right to vote your shares, by attending the Meeting and voting in person.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quorum</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The presence, in person or by proxy, of two or more shareholders holding or representing, in the aggregate, at least twenty-five percent (25%) of our company&#8217;s voting rights will constitute a quorum at the Meeting.&#160; No business will be considered or determined at the Meeting unless the requisite quorum is present within half an hour from the time designated for the Meeting.&#160; If within half an hour from the time designated for the Meeting a quorum is not present, the Meeting will stand adjourned to the same day in the following week, at the same time and place.&#160; At least two shareholders present, in person or by proxy, will constitute a quorum at the adjourned meeting.&#160; This notice will serve as notice of such reconvened meeting if no quorum is present at the original date and time and no further notice of the reconvened meeting will be given to shareholders.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">2</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Abstentions and broker non-votes will be counted towards the quorum.&#160; Broker non-votes occur when brokers that hold their customers&#8217; shares in street name sign and submit proxies for such shares and vote such shares on some matters but not on others.&#160; This occurs when brokers have not received any instructions from their customers, in which case the brokers, as the holders of record, are permitted to vote on &#8220;routine&#8221; matters, but not on non-routine matters.&#160; The only item on the Meeting agenda that may be considered routine is Proposal 3 relating to the reappointment of the Company&#8217;s independent auditors for the fiscal year ending December 31, 2016 and for such additional period until our next annual general meeting for 2017; however, we cannot be certain whether this will be treated as a routine matter. Absent specific instructions from the beneficial owner of the shares, brokers are not allowed to exercise their voting discretion, among other things, with respect to the election of directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Unsigned or unreturned proxies, including those not returned by banks, brokers, or other record holders, will not be counted for quorum or voting purposes.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Vote Required for Approval of the Proposals</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Each ordinary share entitles the holder to one vote.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to approve each of the proposals.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In addition, for the approval of Proposal 4, one of the following two voting requirements must be met: (i) at least a majority of the shares held by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter, present in person or by proxy and voting on the matter at the Meeting (excluding abstentions), voted in favor of the proposal, or (ii) the total number of shares voted against the proposal by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter, does not exceed two-percent (2%) of our outstanding voting rights.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are unaware of any shareholder that would be deemed to be a controlling shareholder of our company as of the current time for purposes of Proposal 4.&#160; A shareholder who signs and returns a proxy card will be deemed to be confirming that such shareholder, and any related party of such shareholder, is not a controlling shareholder for purposes of Proposal 4.&#160; If you believe that you, or a related party of yours, may be deemed to be a controlling shareholder and you wish to participate in the vote on Proposal 4, you should contact our Chief Financial Officer, Lior Torem, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>liort@check-cap.com</u></font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>&#160;</u></font>or +972-4-8303401 or Dana Zigman-Behrend, General Counsel, at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>dana.behrend@check-cap.com</u></font> or +972-4-8303424.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The Israeli Companies Law, 1999 (the &#8220;Companies Law&#8221;) requires that each shareholder voting on Proposal 4 indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at the Meeting, whether or not the shareholder has a personal interest in such proposal.&#160; Otherwise, the shareholder is not eligible to vote on the proposal and his or her vote will not be counted for the purposes of the proposal.&#160; Under the Israeli Companies Law, a &#8220;personal interest&#8221; of a shareholder in an act or transaction of a company (i) includes a personal interest of (a) any spouse, sibling, parent, grandparent or descendant of the shareholder, any descendant, sibling or parent of a spouse of the shareholder and the spouse of any of the foregoing; and (b) a company with respect to which the shareholder (or any of the foregoing relatives of the shareholder) owns at least 5% of the outstanding shares or voting rights, serves as a director or chief executive officer or has the right to appoint one or more directors or the chief executive officer; and (ii) excludes a personal interest arising solely from the ownership of shares.&#160; Under the Israeli Companies Law, in the case of a person voting by proxy, &#8220;personal interest&#8221; includes the personal interest of either the proxy holder or the shareholder granting the proxy, whether or not the proxy holder has discretion how to vote.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In tabulating the voting results for any particular proposal, shares that constitute broker non-votes and abstentions are not considered votes cast on that proposal.&#160; Unsigned or unreturned proxies, including those not returned by banks, brokers, or other record holders, will not be counted for voting purposes. Therefore, it is important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its shares if the shareholder wants its shares to count towards the vote tally for a given proposal.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">3</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cost of Soliciting Votes for the Meeting</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We will bear the cost of soliciting proxies from our shareholders.&#160; Proxies will be solicited by mail and may also be solicited in person, by telephone or electronic communication, by our directors, officers and employees.&#160; We will reimburse brokerage houses and other custodians, nominees and fiduciaries for their expenses in accordance with the regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) concerning the sending of proxies and proxy material to the beneficial owners of our shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Security Ownership of Certain Beneficial Owners and Management</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The following table sets forth certain information as of November 15, 2016 (unless otherwise indicated below) regarding the beneficial ownership by (i) each person known to us to beneficially own more than 5% of our outstanding ordinary shares; (ii) each of our directors and executive officers; and (iii) all of our current directors and executive officers as a group.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The percentage of beneficial ownership of our ordinary shares is based on 14,455,075 ordinary shares outstanding as of November 15, 2016.&#160; Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting power or investment power with respect to securities.&#160; All options and warrants currently exercisable or exercisable into ordinary shares within 60 days of November 15, 2016 are deemed to be outstanding and beneficially owned by the shareholder holding such options or warrants for the purpose of computing the number of shares beneficially owned by such shareholder.&#160; Such shares are also deemed outstanding for purposes of computing the percentage ownership of the person holding the option or warrant.&#160; They are not, however, deemed to be outstanding and beneficially owned for the purpose of computing the percentage ownership of any other shareholder.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Except as described in the footnotes below, we believe each shareholder has voting and investment power with respect to the ordinary shares indicated in the table as beneficially owned.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z4045ba027be541f88618eed62e6ee4cf" cellspacing="0" cellpadding="0" align="right">
<tr>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom"></td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ordinary Shares</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially Owned</div>
</div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</div>
</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Percent</div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; VERTICAL-ALIGN: top" valign="bottom" colspan="8">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5% or Greater Shareholders</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(other than directors and executive officers)</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Pontifax Funds</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">2,561,835.5</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">16.39</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Shanghai Fosun Pharmaceutical Group Co. Ltd.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup></div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">2,197,366</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">14.53</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Quant Global Capital Advisors, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup></div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">1,666,666</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">10.90</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yoav and Sigalit Kimchy</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">746,490</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">5.29</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Directors and Executive Officers</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">William (Bill) Densel</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(5)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">336,059</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">2.27</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Lior Torem</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(6)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">138,061</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Alex Ovadia</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(7)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">133,078</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yoav Kimchy</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">771,490</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">5.29</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Tomer Kariv</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">2,561,835.5</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">16.39</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">XiangQian (XQ) Lin</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(8)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">392,813</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">2.68</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Walter L. Robb</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(9)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">441,802</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">3.04</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yuval Yanai</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">35,284</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Mary Jo Gorman</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">30,244</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Steven Hanley</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">44,093</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 76%; VERTICAL-ALIGN: top" valign="bottom">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Directors and executive officers as a group (10 persons)</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(10)</sup></div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">4,884,759.50</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 9%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">32.30</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">%</div>
</td>
</tr>
</table>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; CLEAR: both; FONT-SIZE: 10pt">__________________</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">*Less than 1% of our ordinary shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z3b5cc9563bc047ec94a90e6be59024c8" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes ordinary shares directly held by Pontifax (Cayman) II, L.P., Pontifax (Israel) II, L.P. and Pontifax (Israel) II&#8212;Individual Investors, L.P (collectively, the &#8220;Pontifax Funds&#8221;).&#160; Pontifax Management II L.P. is the general partner of the Pontifax Funds and Pontifax Management 2 G.P. (2007) Ltd. is the general partner of Pontifax Management II L.P.&#160; Tomer Kariv and Ran Nussbaum are Managing Partners of each of the Pontifax Funds and Pontifax Management II L.P. and are directors of Pontifax Management 2 G.P. (2007) Ltd. and share voting and dispositive power with respect to the shares.&#160; The principal business office of each of the foregoing entities and persons is 8 Hamanofim Street, Beit Ofek, Herzliya Pituach, Israel.&#160; Based also on information contained in a Schedule 13D/A filed by Pontifax Funds with the SEC on <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">April 11, 2016</font>, includes (i) 1,385,610 outstanding ordinary shares; (ii) <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">749,334</font> ordinary shares subject to warrants that are currently exercisable; (iii) 239,391.5 ordinary shares issuable upon exercise of the Series A Warrants <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">that are currently exercisable ; and (iv) 187,500 ordinary shares issuable upon exercise of the Long Term Incentive Warrants that are currently exercisable</font>.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">4</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z82895ac3468f4a2680efa529fcf6e574" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Based solely on information contained in a Schedule 13G/A filed by Shanghai Fosun Pharmaceutical Group Co. Ltd. with the SEC on <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">January 28, 2016</font>.&#160; Includes<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">: (i) 1,530,699 outstanding ordinary shares; (ii) 333,333.5 ordinary shares issuable upon exercise of the Series A Warrants that are currently exercisable; and (iii) 333,333.5 ordinary shares issuable upon exercise of the Long Term Incentive Warrants that are currently exercisable.</font></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zc7cdc042945d4da3b5cac17bafd85b88" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(3)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Based on our records, including information contained in a Schedule 13G filed by Quant Global Capital Advisors, LLC with the SEC on March 6, 2015. Includes: (i) 833,333 outstanding ordinary shares; (ii) 416,666.5 ordinary shares issuable upon exercise of the Series A Warrants that are currently exercisable; and (iii) 416,666.5 ordinary shares issuable upon exercise of the Long Term Incentive Warrants that are currently exercisable.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z09dd3d248da345c4ba215ad497f779ef" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(4)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes: (i) 319,553 ordinary shares are directly held by Yoav Kimchy; (ii) 107,384 ordinary shares subject to options held by Yoav Kimchy that are currently exercisable; and (iii) 319,553 ordinary shares are directly held by Sigalit Kimchy.&#160; Yoav Kimchy, our chief technology officer, and Sigalit Kimchy are husband and wife.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zd561073aac6c43f2b6d9dc37c70ce42e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(5)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes 336,059 ordinary shares subject to options that are currently exercisable or exercisable within 60 days of this table.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z5ddd4fec9f734524990c4a76dbe6cdab" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(6)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes 124,745 ordinary shares subject to options that are currently exercisable or exercisable within 60 days of this table.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z341aaaf286c640459cfe4882b28fcafe" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(7)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes: 116,411 ordinary shares subject to options that are currently exercisable or exercisable within 60 days of this table.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zd635553843de4579a4d3db18fdde9979" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(8)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes: (i) 166,667 outstanding ordinary shares held by Esco Ventures Pte Ltd.; (ii) 83,333.5 ordinary shares issuable upon exercise of the Series A Warrants, that are currently exercisable, held by Esco Ventures Pte Ltd.; (iii) 83,333.5 ordinary shares issuable upon exercise of the Long Term Incentive Warrants, that are currently exercisable, held by Esco Ventures Pte Ltd and (iv) 59,479 ordinary shares subject to options that are exercisable within 60 days of this table, held directly by XiangQian (XQ) Lin. Mr. Lin has advised us that Esco Ventures Pte Ltd. is wholly-owned by him and that he possesses the ultimate voting and investment power over the shares beneficially owned by Esco Ventures Pte Ltd.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z017cbe2559d647419a8a8fad39a5d7b2" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.85pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(9)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Includes: (i) 356,075 outstanding ordinary shares held by Counterpoint Ventures Fund LP and Counterpoint Ventures Fund II LP (together, the &#8220;Counterpoint Funds&#8221;); (ii) 21,250 ordinary shares issuable upon exercise of the Series A Warrants, that are currently exercisable, held by the Counterpoint Funds; (iii) 21,250 ordinary shares issuable upon exercise of the Long Term Incentive Warrants, that are currently exercisable, held by the Counterpoint Funds; and (iv) 43,227 ordinary shares subject to options that are currently exercisable or exercisable within 60 days of this table, held directly by Mr. Robb. Mr. Robb has advised us that the general partner of each of the Counterpoint Funds is Lion Development LLC, which is 99% controlled by Mr. Walter Robb, and as such, Walter Robb possesses the ultimate voting and investment power over the shares beneficially owned by the Counterpoint Ventures entities.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z1e9707866e06421584a120f2d4c8c1d5" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 23px; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(10)</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">See footnotes (1)-(9) for certain information regarding beneficial ownership.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">5</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Executive Officer Compensation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The table below sets forth the compensation paid to our five most highly compensated senior office holders (as defined in the Israeli Companies Law) during or with respect to the year ended December&#160;31, 2015, in the disclosure format based on Regulation 21 of the Israeli Securities Regulations (Periodic and Immediate Reports), 1970. We refer to the five individuals for whom disclosure is provided herein as our &#8220;Covered Executives.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">For purposes of the table and the summary below, and in accordance with the above mentioned securities regulations, &#8220;compensation&#8221; includes salary cost, consultancy fees, bonuses, equity-based compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits and any undertaking to provide such compensation.&#160; All amounts reported in the table are in terms of cost to us, as recognized in our financial statements for the year ended December 31, 2015 plus compensation paid to such Covered Executive following the end of the year in respect of services provided during the year. Each of the Covered Employees was covered by our directors&#8217; and officers&#8217; liability insurance policy and was entitled to indemnification and exculpation in accordance with indemnification and exculpation agreements that we previously entered into with them.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The exchange rate that we used to calculate the &#8220;Salary Cost&#8221; of our c<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">hief financial officer</font>, <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">chief technology officer</font> and chief operations officer<font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</font>and Israeli site manager, as presented in the following table, was NIS&#160;3.8869 to US$1.00, and is provided herein for convenience (such exchange rate is based on the average of 12 months last-day exchange rate during 2015, as published by the Bank of Israel).</div>

<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z6621fd8c6bb4470b8fca2c4311052842" cellspacing="0" cellpadding="0" align="right">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="TEXT-ALIGN: left; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Name and Principal Position</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Salary Cost</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup></div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Bonus</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(3)</sup></div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(4)</sup></div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Share-Based<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br>
</font>Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(5)</sup></div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; VERTICAL-ALIGN: bottom" valign="bottom" colspan="18">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">US$</div>
</td>
<td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 32.11%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">William Densel - chief executive officer and&#160; director</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">247,840</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">43,750</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(6)</sup>&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">538,239</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">829,829</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 32.11%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Guy Neev - former chief executive officer</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">389,303</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">84,000</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">140,000</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">896,436</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">1,509,739</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 32.11%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Lior Torem - chief financial officer</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">275,729</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">27,500</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">224,109</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">527,338</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 32.11%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Yoav Kimchy - <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">chief technology officer</font> and former director</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">291,093</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">36,000</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(6)</sup>&#160;</div>
</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">224,109</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">551,202</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 32.11%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Alex Ovadia - chief operations officer&#160;and VP R&amp;D</div>
</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">350,889</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">36,000</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">-</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">224,109</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff; WIDTH: 10.12%; VERTICAL-ALIGN: bottom" valign="bottom">
<div style="LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">610,998</div>
</td>
<td style="TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; WIDTH: 1.12%; VERTICAL-ALIGN: bottom" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25; CLEAR: both">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z185a72fe88fa4b389d9615758940ef28" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Unless otherwise indicated herein, all Covered Executives are employed on a full-time (100%) basis</font>.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zf876c2a2d34b4dfbb909e2d48f022db5" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Salary cost includes the Covered Executive&#8217;s gross salary plus payment of social benefits made by us on behalf of such Covered Executive.&#160; Such benefits may include, to the extent applicable to the Covered Executive, payments, contributions and/or allocations for savings funds, education funds, pension, severance, risk insurances, payments for social security and tax gross-up payments, vacation, car, medical insurances and benefits, convalescence or recreation pay and other benefits and perquisites consistent with our policies.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zb4ce2eae385942ceb09c2a4702a37220" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(3)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Represents annual bonuses granted to the Covered Executives based on formulas set forth in their respective employment agreements</font>.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z33c9024d44e64c3b85db593b887c453f" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(4)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Represents a one-time severance fee made by us to Mr. Guy Neev, our former chief executive officer, who served as our chief executive officer and a director from April 2009 until August 2015 and served as an employee until January 31, 2016.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z46265ef4ae2d4289baaafd5960bbdd24" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(5)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Represents the share-based compensation expenses recorded in our consolidated financial statements for the year ended December 31, 2015 based on the fair value of the grant date of the options, in accordance with accounting guidance for equity-based compensation.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zcebf2ba3d77b4c71bbf50e4b4d071c7e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(6)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Bonus includes amounts that are subject to shareholder approval at the Meeting, as described in Proposals 4 and 5 of this Proxy Statement.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z25aaef355cdf4805abf999b86269a49e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">(7)</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The table does not include information regarding warrants to the Pontifax Funds to purchase an aggregate of 221,539 of our ordinary shares at an exercise price of NIS 0.20 per share, or the Pontifax Warrants, in consideration of their commitment to provide to us business development services and a representative designated by Pontifax to serve as the chairman of our board of directors.&#160; Upon the closing of our initial public offering any unvested portion of the warrants became fully vested and exercisable. For additional information regarding the Pontifax Warrants, see Item 7.B. &#8220;Major Shareholders and Related Party Transactions&#8212;Related Party Transactions &#8212; Pontifax Warrants&#8221; of our annual report on Form 20-F for year ended December 31, 2015, as filed with the SEC March 15, 2016, and Note 16A to our audited consolidated financial statements for year ended December 31, 2015 included therein.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">6</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPOSAL 1</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ELECTION OF DIRECTORS</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(Items 1 on the Proxy Card)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under our articles of association, our Board of Directors must consist of at least four and not more than eleven directors, including at least two external directors required to be appointed under the Israeli Companies Law.&#160; Our Board of Directors currently consists of seven directors, including two external directors.&#160; Each of our directors (other than external directors under the Israeli Companies Law) holds office until the next annual general meeting of shareholders following his or her appointment (unless the tenure of such director expires earlier or a director is removed from office pursuant to the Israeli Companies Law).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">At the Meeting, all of our current directors who are not external directors (within the meaning of the Israeli Companies Law) are standing for reelection at the Meeting, to hold office until our next annual general meeting of shareholders and until his successor is elected and qualified.&#160; Each of our two external directors, Mr. Yuval Yanai and Dr. Mary Jo Gorman, will continue to serve in accordance with their respective three-year terms.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In accordance with the Israeli Companies Law, each of the nominees for election to our Board of Directors has certified to us that he meets all the requirements of the Israeli Companies Law for election as a director of a public company, and possesses the necessary qualifications and is able to dedicate sufficient time, to fulfill his duties as a director of our company, taking into consideration our company&#8217;s size and special needs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In accordance with the exemption available to foreign private issuers under the Listing Rules of the NASDAQ Stock Market, we are not obligated to follow the requirements of the NASDAQ Listing Rules with regard to the process of nominating directors, and instead, follow Israeli law and practice, in accordance with which our Board of Directors (or a committee thereof) is authorized to recommend to our shareholders director nominees for election.&#160; However, in October 2015, our Board of Directors voluntarily established a Nominating Committee, whose role is to select and recommend to the Board of Directors for selection, director nominees, while considering the appropriate size and composition of the Board of Directors, the requirements applicable to all members of the Board of Directors and the criteria for the selection of new members of the Board of Directors.&#160; The Nominating Committee is currently comprised of the following directors: Yuval Yanai (an external director within the meaning of the Israeli Companies Law and an independent director within the meaning of the NASDAQ Listing Rules), who serves as the Chairman of the Nominating Committee, Tomer Kariv (the Chairman of our Board of Directors) and Steven Hanley (an independent director within the meaning of the NASDAQ Listing Rules).&#160; Upon the recommendation of our Nominating Committee, our Board of Directors has nominated the five individuals named below for election, to hold office until our next annual general meeting of shareholders, subject to our articles of association.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nominees for Director</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The following information is provided with respect to each director nominee based upon our records and information provided to us by each nominee.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Tomer Kariv</font> has served as a member of our Board of Directors since June 2009 and as the chairman of our Board of Directors since July 2010.&#160; Mr. Kariv has served as a member of the board of directors of Check Cap Ltd. (Delaware) and a manager of Check-Cap LLC since March 2008.&#160; Mr. Kariv is the co-founder and since December 2004, has served as Chief Executive Officer of Pontifax, a group of Israeli-based life sciences venture funds focusing on investments in bio-pharmaceutical and med-tech technologies.&#160; Mr. Kariv has also served as an active board member of many of the funds&#8217; portfolio companies, assuming a special responsibility for strategic planning.&#160; Among others, since March 2008, Mr. Kariv has served as a board member of Macrocure Ltd. and Arno Therapeutics Inc. In addition, Mr. Kariv&#160;serves as a board member of Otic Pharma Ltd. and EyeYon Medical Ltd.&#160; During the 10 years prior to establishing Pontifax, Mr. Kariv played a key role in investing, managing and nurturing technology driven companies and startups and has held senior management positions at top Israeli financial institutions.&#160; Mr. Kariv practiced law with Sullivan &amp; Cromwell, a leading law firm in New York, and holds a B.A. degree in Economics from Harvard University and a J.D. from Harvard Law School.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">7</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">William (Bill) Densel&#160;</font>has served as our Chief Executive Officer and a member of our Board of Directors since August 2015. Mr. Densel served as the President and Chief Executive Officer and member of the Board of Directors of our U.S. subsidiary, Check-Cap US, Inc., since July 2015. Mr. Densel has a 25-year leadership career, including in his recent roles as Chief Executive Officer of Beacon Endoscopic, Inc. (2013), which was acquired by Covidien plc.; as General Manager, CardioSCORE for BG Medicine Inc. (2012-2013); and at Dune Medical Devices, Inc. (2009-2011), lastly as Chief Executive Officer. Mr. Densel has effectively led teams and utilized his influence across key decision makers in larger organizations such as Cytyc Corporation (2006-2009), which was acquired by Hologic in 2007, where he served in several positions, including Vice President, Marketing &#8211; GYN Surgical, Vice President, Emerging Surgical Technologies and Senior Director, Neuroscience; Boston Scientific Corporation (2004-2006), where he served as Director, New Market Development &amp; Strategic Planning &#8211; Endosurgery; and Genzyme Biosurgery, where he served in various positions, lastly as Senior Director, Marketing and Business Development - General and GYN Surgery (1993-2004). Mr. Densel served in the U.S. Navy from 1989 to 1993, lastly as Lieutenant, Special Operations. Mr. Densel has a BA degree in Economics from Duke University.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Steven Hanley</font> has served as a member of our Board of Directors since February 2015.&#160; Mr. Hanley is currently the Co-Founder, board member and Chief Executive Officer of MediBeacon Inc., an optical diagnostic company based in St. Louis, Missouri formed upon acquiring assets and intellectual property from Covidien in 2012.&#160; Mr. Hanley is an experienced global business leader who has managed highly complex pharmaceutical and medical device operations with annual global revenue exceeding $1 billion.&#160; As the President of Covidien plc&#8217;s Imaging Solutions business unit, Mr. Hanley led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development.&#160; Internationally, Mr. Hanley&#8217;s track record includes numerous new drug and device product introductions and sales force expansion in Eastern Europe, China and Latin America.&#160; Mr. Hanley is experienced working in different cultures and successfully navigating dynamic regulatory environments.&#160; Over his nearly 18 years with the Covidien family of companies, Mr. Hanley developed a large network of business leaders and clinicians to help determine market needs, commercial potential and product positioning.&#160; As a sales leader, Mr. Hanley called on radiologists, nuclear medicine physicians, cardiologists, as well as surgeons in specialties including general, orthopedic, and OB/GYN.&#160; Mr. Hanley is Principal and Founder of Neem LLC, which was founded in 2009 to focus on startup and entrepreneurial medical device and other life science companies with whom the firm works to bridge the gap between breakthrough technology and commercialization.&#160; Mr. Hanley is the Chairman of the Board of Managers for Daya CNS LLC, based in St Louis Missouri.&#160; In addition, Mr. Hanley is currently on the Advisory Board for Kogent Surgical LLC, based in St Louis Missouri.&#160; Mr. Hanley has his bachelor&#8217;s and master&#8217;s degrees in business administration from Marquette University.&#160; Mr. Hanley provided consultancy services to us on behalf of Neem LLC from November 2009 until December 31, 2014 and served as a Scientific Advisor to our company from June 2011 until his election to our Board of Directors in February 2015.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">XiangQian (XQ) Lin</font> has served as a member of our Board of Directors, since February 2015.&#160; In addition, we have engaged Mr. Lin to provide to us certain business development services in Asia since June 1, 2015. Mr. Lin has served as the Group President and Chief Executive Officer of the Esco Group of Companies, a leading global life sciences tools provider active in laboratory, medical and pharmaceutical equipment based in Singapore, since February 2011.&#160; Since 2014, Mr. Lin has also served as the Managing Partner of Esco Ventures, a strategic investment arm of the Esco Group of Companies, focused on early stage investment in life sciences tools and med-tech start-ups, since he founded it in August 2014.&#160; From January 1997 until February 2011, Mr. Lin held various positions, lastly as Vice President, of Esco Micro Pte Ltd., a family business which he re-engineered into a successful life sciences tools company when he founded the Esco Biotech unit in 2000.&#160; From January 2007 to December 2010, Mr. Lin also served as the President of Esco Technologies, Inc., a wholly-owned U.S. subsidiary of Esco Micro Pte Ltd., which he established following a buy-out of a joint venture partner.&#160; Mr. Lin is the only non-U.S. member of the US NSF Standard 49 Joint Committee and is also a member of the Singapore Venture Capital and Private Equity Association. Mr. Lin holds a BSc degree in Economics from the Wharton School, University of Pennsylvania.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">8</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Walter L. Robb</font> has served as a member of our Board of Directors since May 2009.&#160; Dr. Robb has served as a member of the Board of Directors of Check Cap Ltd. (Delaware) and a manager of Check-Cap LLC since February 2005.&#160; Dr. Robb is the general partner of each of Counterpoint Ventures Fund LP, established in 2004, and Counterpoint Ventures Fund II LP, established in 2011.&#160; Since 2009, Dr. Robb has served as the interim Chief Executive Officer of Cyclics Corporation, which manufactures and supplies resins and thermoplastic tooling products.&#160; Since 1993, Dr. Robb has served as a management consultant and president of Vantage Management, Inc. a private investment and consulting firm. Dr. Robb served as a member of the boards of directors of Celgene Corporation from 1992 to 2011, and has served as a member of the board of directors of Mechanical Technology, Inc. since 2000.&#160; Dr. Robb has also served as a director in several start-up companies over the last 20 years.&#160; Until 1993, Dr. Robb served as senior vice president and director for corporate research and development for General Electric, and served on General Electric&#8217;s Corporate Executive Council from 1986 to 1993.&#160; Dr. Robb was the director of GE Medical Systems from 1973 to 1986.&#160; In September 1994, Dr. Robb received the National Medal of Technology from President Clinton for leadership in the CT and MR Imaging Industry.&#160; Dr. Robb holds a BS degree in chemical engineering from Penn State University and an MS degree and PhD in chemical engineering, both from the University of Illinois.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Board of Directors has determined that each of Messrs. Yuval Yanai, Steven Hanley, Walter L. Robb and Dr. Mary Jo Gorman meet the independence requirements under the NASDAQ Listing Rules.&#160; Accordingly, subject to shareholder approval of the above director nominees, our Board of Directors will consist of seven members, four of whom satisfy the independence requirements of the NASDAQ Listing Rules. In addition, Mr. Yanai and Dr. Gorman serve as our external directors within the meaning of and as required under the Israeli Companies Law.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are not aware of any reason why the nominees, if elected, would be unable or unwilling to serve as directors.&#160; Should the nominees be unavailable for election, the proxies will be voted for substitute nominees designated by our Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to elect as directors the nominees named above.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Board of Directors recommends a vote FOR the election of each nominee for director named above.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPOSAL 2</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPROVAL OF COMPENSATION FOR NON-EMPLOYEE DIRECTORS (OTHER THAN THE </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CHAIRMAN OF THE BOARD OF DIRECTORS AND EXTERNAL DIRECTORS)</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><br>
</font> (Item 2 on the Proxy Card)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the terms of remuneration paid to a director of a public company require the approval of the compensation committee, board of directors and the shareholders, in that order.&#160; Subject to the election of the director nominees listed in Proposal 1, our Compensation Committee and Board of Directors have approved, subject to shareholder approval, the payment to each such director who is not an employee (other than the Chairman of our Board of Directors and our external directors, within the meaning of the Israeli Companies Law) of an annual fee of US$45,000, paid on a quarterly basis.&#160; As approved by our shareholders at an extraordinary general meeting held on May 19, 2015, our external directors (within the meaning of the Israeli Companies Law) are entitled to the same annual fee for the duration of their respective initial three-year terms.&#160; In addition, if elected at the Meeting, our directors will continue to benefit from the directors&#8217; and officers&#8217; indemnification and exculpation agreement that we previously entered into with them, as well as from our directors&#8217; and officers&#8217; liability insurance policy.&#160; The directors, if elected, will also be entitled to reimbursement of expenses (including travel, stay and lodging), subject to the Israeli Companies Law and the regulations promulgated thereunder, and in accordance with our company practices and our Compensation Policy for Executive Officers and Directors as approved by our shareholders on August 13, 2015 (the &#8220;Compensation Policy&#8221;).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">9</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The proposed payment of an annual fee to our non-employee directors (other than the Chairman of our Board of Directors and our external directors) and other compensation terms are consistent with our Compensation Policy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">It is therefore proposed that at the Meeting, the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 35.45pt; FONT-SIZE: 10pt">&#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RESOLVED</font>, to approve the payment to each of the non-employee directors of the Company (other than the Chairman of the Board of Directors and the external directors), of an annual fee of US$45,000, paid on a quarterly basis, and the other compensation terms described in Proposal 2 of the Proxy Statement for the 2016 Annual General Meeting of Shareholders, subject to their election at the Meeting.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the approval of the compensation for directors requires the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Board of Directors recommends a vote FOR the foregoing resolution.&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPOSAL 3</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RATIFICATION AND APPROVAL OF APPOINTMENT OF INDEPENDENT REGISTERED </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PUBLIC ACCOUNTANTS</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(Item 3 on the Proxy Card)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">At the Meeting, shareholders will be asked to ratify and approve the re-appointment of Brightman Almagor Zohar &amp; Co., registered public accounting firm, a member firm of Deloitte Touche Tohmatsu, as our independent registered public accountants for the fiscal year ending December 31, 2016 and for such additional period until our next annual general meeting, pursuant to the recommendation of our Audit Committee and Board of Directors.&#160; Brightman Almagor Zohar &amp; Co. has no relationship with us or our U.S. subsidiary except as independent registered public accountants and, from time to time and to a limited extent, as tax consultants and providers of some audit-related services.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">In accordance with our Articles of Association and applicable law, our Board of Directors determines, at its discretion, the compensation of Brightman Almagor Zohar &amp; Co. for audit and other services, in accordance with the volume and nature of their services, pursuant to the pre-approval and recommendation of our Audit Committee.&#160; Pursuant to the pre-approval and recommendation of our Audit Committee, our Board of Directors has approved the engagement of Brightman Almagor Zohar &amp; Co for: (i) the audit of our annual financial statements for the year ended December 31, 2016 and the first three quarters in the year ending December 31, 2017, for a total remuneration of up to US$60,000; and (ii) non-audit services for the year ending December 31, 2016, for a total remuneration of up to US$60,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">It is therefore proposed that at the Meeting, the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 53.85pt">&#8220;<font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RESOLVED</font>, that the appointment of Brightman Almagor Zohar &amp; Co., a member firm of Deloitte Touche Tohmatsu, as the independent registered public accountants of the Company for the year ending December 31, 2016 and for such additional period until the next annual general meeting, be and hereby is ratified and approved, whose compensation for such services is determined by the Board of Directors of the Company, at its discretion, in accordance with the volume and nature of their services, pursuant to the pre-approval and recommendation of the Audit Committee of the Company.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to approve the foregoing resolution.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Board of Directors recommends a vote FOR the foregoing resolution.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">10</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPOSAL 4</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPROVAL OF PAYMENT OF THE DISCRETIONARY COMPONENT OF THE 2015 BONUS </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TO OUR CHIEF EXECUTIVE OFFICER</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(Item 4 on the Proxy Card)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the payment of compensation to a Chief Executive Officer must be approved by the compensation committee, board of directors and shareholders by a special majority, in that order.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">William (Bill) Densel has served as our Chief Executive Officer and a member of our Board of Directors since August 2015.&#160; Mr. Densel served as our President of U.S. Operations from May 2015 until August 2015 and has served as the President and Chief Executive Officer of our U.S. subsidiary, Check-Cap U.S. Inc., since July 2015.&#160; See Item 1 for details regarding Mr. Densel&#8217;s professional experience and background.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The employment agreement of Mr. Densel for his service as our President of U.S. Operations, which was approved by our shareholders on May 19, 2015, provided, and the employment agreement of Mr. Densel for his service as our Chief Executive Officer, which was approved by our shareholders on August 13, 2015, provides for an annual bonus of up to 50% of his annual base salary, respectively (which is consistent with our Compensation Policy), subject to the achievement of certain criteria for each 12 month-period (or such shorter or longer period determined by our Compensation Committee and Board of Directors ), as shall be determined by our Compensation Committee and Board of Directors, in accordance with our Compensation Policy, as in effect from time to time.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">According to Mr. Densel&#8217;s 2015 bonus plan, as approved by our shareholders on December 1, 2015, up to 20% of Mr. Densel&#8217;s pro-rated annual cash bonus for the period ended December 31, 2015, will be based on an evaluation of Mr. Densel&#8217;s overall performance during such period by our Board of Directors, in accordance with our Compensation Policy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Compensation Committee and Board of Directors evaluated, among other things, Mr. Densel&#8217;s performance and contribution to advancing our company&#8217;s long-term goals and objectives during such 2015 period, including, the following contributions:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z969fe8b920014801a176ff86537888f2" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Leading the progress of the Company&#8217;s clinical data generation and public dissemination to include a peer-reviewed publication and presentations in major clinical meetings.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zb4f30fcfa7b04328822edda60b201ca4" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Broadening the awareness of the Company in the financial community and national and trade media publications.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z18975739482e4c15845c4d0d26941220" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Developing and deepening key relationships with key opinion leaders in the clinical community and industry.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="zfc19b7ec18b94fe9b5ecd87f4d97a6e3" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Effectively managing our financial resources, which enabled our cash balance to exceed US$14 million at the end of 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">After evaluation of Mr. Densel&#8217;s performance and his contribution to the achievement of our company&#8217;s long-term goals and objectives during such 2015 bonus period (as detailed above), our Compensation Committee and Board of Directors determined that Mr. Densel is entitled to the entire 20% discretionary component of the 2015 annual bonus; however, our Compensation Committee and Board of Directors resolved to reduce Mr. Densel&#8217;s bonus payout by 40% as part of an overall reduction in the 2015 bonus payouts to our management members, in view of our research and development stage as well as our current cash position and expected burn rate.&#160; Accordingly, our Compensation Committee and Board of Directors approved, and recommend that the shareholders approve, the payment to Mr. Densel of US$10,500 in respect of the 20% discretionary bonus (which is equal to 40% of the 20% discretionary component of his 2015 pro-rated annual bonus), and determined that such bonus is fair and reasonable under the circumstances.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">It is therefore proposed that at the Meeting the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 53.85pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;RESOLVED</font>, that the payment to Mr. William (Bill) Densel of a cash bonus in the amount of US$10,500 in respect of his performance as the Chief Executive Officer during the 2015 pro-rated bonus period, as described in Proposal 4 of the Proxy Statement for the 2016 Annual General Meeting of Shareholders, be and hereby is approved.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">11</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to approve the foregoing resolution, provided that either: (i) at least a majority of the shares held by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter, present in person or by proxy and voting on the matter at the Meeting (excluding abstentions), voted in favor of the proposal, or (ii) the total number of shares voted against the proposal by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the matter does not exceed two-percent (2%) of our outstanding voting rights.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">The Israeli Companies Law requires that each shareholder voting on this proposal indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at the Meeting, whether or not the shareholder has a personal interest in the proposal.&#160; Otherwise, the shareholder is not eligible to vote on this proposal and his or her vote will not be counted for the purposes of this proposal.&#160; For details regarding the meaning of &#8220;personal interest,&#8221; see &#8220;Vote Required for Approval of the Proposals.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Board of Directors recommends a vote FOR the foregoing resolution.&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPOSAL 5</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPROVAL OF PAYMENT OF THE DISCRETIONARY COMPONENT OF THE 2015 BONUS </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TO OUR CHIEF TECHNOLOGY OFFICER (AND FORMER DIRECTOR)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(Item 5 on the Proxy Card)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the compensation of a director of a public company for service as a director or in any other capacity requires the approval of the compensation committee, board of directors and shareholders, in that order.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Dr. Yoav Kimchy has served as our Chief Technology Officer since our inception in April 2009 and a member of our Board of Directors from April 2009 and until December 2015.&#160; Dr. Kimchy founded Check-Cap LLC in December 2004, serving as its president and Chief Executive Officer until March 2008, and as its president and Chief Technology Officer since March 2008.&#160; Dr. Kimchy has also served as a member of the board of directors of Check-Cap Ltd. (Delaware), the manager of Check-Cap LLC, since December 2004.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under Dr. Kimchy&#8217;s compensation terms as Chief Technology Officer, as approved by our Board of Directors in August 2014 and by our shareholders in September 2014, he is entitled to an annual bonus of up to 30% of his annual salary (which is consistent with our Compensation Policy), at the discretion of the Board of Directors, upon the achievement of certain milestones determined by the Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">According to Dr. Kimchy&#8217;s 2015 bonus plan, as approved by our shareholders on December 1, 2015, up to 20% of Dr. Kimchy&#8217;s annual cash bonus for the period ended December 31, 2015, will be based on an evaluation of Dr. Kimchy&#8217;s overall performance during such period by our Board of Directors, in accordance with our Compensation Policy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Compensation Committee and Board of Directors evaluated, among other things, Dr. Kmichy&#8217;s performance and contribution to advancing our company&#8217;s long-term goals and objectives during such 12-month period, including, the following contributions:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z02fb4501c5044efd975fb667ec8d3ecb" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Significant contribution to the successful consummation of the Company&#8217;s initial public offering in the United States and simultaneous private placement, attracting major industry investors.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z1d627a51e702461097df7893b0b682c3" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Providing strong technical leadership to the research and development team in conjunction with product design and development advancement.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z90da00b7b96b483d8947e23edc05c260" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="WIDTH: 18pt; FONT-FAMILY: Symbol, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#183;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Leading, together with our Chief Executive Officer, the progress of our clinical data generation and management of public dissemination to include a peer-reviewed publication and presentations in major clinical meetings.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber">12</font></div>

<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000001; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000001; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">After evaluation of Dr. Kimchy&#8217;s performance and his contribution to the achievement of our company&#8217;s long-term goals and objectives during the year ended December 31, 2015 (as detailed above), our Compensation Committee and Board of Directors determined that Dr. Kimchy is entitled to the entire 20% discretionary component of the 2015 annual bonus; however, our Compensation Committee and Board of Directors resolved to reduce Dr. Kimchy&#8217;s bonus payout by 40% as part of an overall reduction in the 2015 bonus payouts to our management members, in view of our research and development stage as well as our current cash position and expected burn rate.&#160; Accordingly, our Compensation Committee and Board of Directors approved, and recommend that the shareholders approve, the payment to Dr. Kimchy of US$8,640&#160; in respect of the 20% discretionary bonus (which is equal to 40% of the 20% discretionary component of his 2015 annual bonus), and determined that such bonus is fair and reasonable under the circumstances.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">It is therefore proposed that at the Meeting, the following resolution be adopted:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 36pt; FONT-SIZE: 10pt; MARGIN-RIGHT: 53.85pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;RESOLVED</font>, that the payment to Dr. Kimchy of a cash bonus in the amount of US$8,640 in respect of his performance as the Chief Technology Officer for the year ended December 31, 2015, as described in Proposal 5 of the Proxy Statement for the 2016 Annual General Meeting of Shareholders, be and hereby is approved.&#8221;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required to approve the foregoing resolution.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The Board of Directors recommends a vote FOR the foregoing resolution.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REVIEW AND DISCUSSION OF FINANCIAL STATEMENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Board of Directors has approved, and its representative will present to the shareholders for review and discussion at the Meeting, our audited financial statements for the year ended December 31, 2015.&#160; This Item will not involve a shareholder vote.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our audited financial statements for the year ended December 31, 2015, which form part of our annual report on Form 20-F for the year ended December 31, 2015 filed with the SEC on March 15, 2016, is available for viewing via the SEC&#8217;s website at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>www.sec.gov</u></font> as well as under the Investors section of our website at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>http://ir.check-cap.com/</u></font>.&#160; Shareholders may receive a hard copy of the annual report on Form 20-F containing the audited financial statements free of charge upon request.&#160; None of the audited financial statements, the Form 20-F nor the contents of our website form part of the proxy solicitation material.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">We are subject to the information reporting requirements of the Exchange Act, as applicable to foreign private issuers.&#160; We fulfill these requirements by filing reports with the SEC.&#160; Our filings with the SEC may be inspected without charge at the SEC&#8217;s Public Reference Room at 100 F Street, N.E., Room 1580 Washington, D.C. 20549.&#160; Information on the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330.&#160; Our SEC filings are also available to the public on the SEC&#8217;s website at <font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>www.sec.gov</u></font>.&#160; As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements.&#160; The circulation of this Proxy Statement should not be taken as an admission that we are subject to those proxy rules.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OTHER MATTERS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Our Board of Directors does not intend to bring any matters before the Meeting other than those specifically set forth in the Notice of 2016 Annual General Meeting of Shareholders and knows of no matters to be brought before the Meeting by others.&#160; If any other matters properly come before the Meeting, it is the intention of the persons named in the accompanying proxy to vote such proxy in accordance with the judgment and recommendation of the Board of Directors.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="z1b10bbd8f96e44cfa42036625a97bd6c" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="WIDTH: 50%; FONT-FAMILY: 'Times New Roman', Times, serif">
<div>By Order of the Board of Directors,</div>

<div>&#160;</div>

<div style="FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal"><u>/s/ Tomer Kariv</u></div>

<div>&#160;</div>

<div>Tomer Kariv</div>

<div style="FONT-STYLE: italic">Chairman of the Board of Directors</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">Date: November 23, 2016</div>

<div style="TEXT-ALIGN: center" id="DSPFPageNumberArea"><font style="FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal" id="DSPFPageNumber"></font>&#160;</div>

<div style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 8pt; FONT-WEIGHT: normal">13</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>PROXY CARD
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.2.0.0
    Copyright 1995 - 2016 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br>
<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>Exhibit 99.2</u></font><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><img style="HEIGHT: 50px; WIDTH: 122px" src="image00001.jpg"></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CHECK-CAP LTD.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The undersigned hereby appoint(s) William (Bill) Densel and Lior Torem, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 0.20 per share, of Check-Cap Ltd. (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Company</font>&#8221;), which the undersigned would be entitled to vote as fully as the undersigned could if personally present at the 2016 Annual General Meeting of Shareholders of the Company to be held on Thursday, December 22, 2016, at 4:00 p.m. (Israel time) at the offices of the Company, the Check-Cap Building, Abba Hushi Avenue, P.O. Box 1271, Isfiya, 30090, Mount Carmel, Israel, and at any adjournment or adjournments thereof, and hereby revoking any prior proxies to vote said shares, upon the following items of business more fully described in the Notice of and Proxy Statement for the 2016 Annual General Meeting of Shareholders (receipt of which is hereby acknowledged):</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">THIS PROXY WILL BE VOTED AS SPECIFIED ON THE REVERSE. IN THE ABSENCE OF SUCH SPECIFICATION, THE SHARES REPRESENTED BY THIS PROXY CARD WILL BE VOTED FOR THE ITEMS SET FORTH ON THE REVERSE.&#160; ON ANY OTHER BUSINESS THAT MAY PROPERLY COME BEFORE THE MEETING, THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THE JUDGMENT OF THE PERSONS NAMED ABOVE AS PROXIES.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">VOTES CAST ON ITEM 4 SET FORTH ON THE REVERSE WILL NOT BE COUNTED UNLESS &#8220;YES&#8221; OR &#8220;NO&#8221; HAS BEEN SPECIFIED AS TO WHETHER THE SHAREHOLDER HAS A PERSONAL INTEREST (AS DEFINED IN THE PROXY STATEMENT) WITH RESPECT TO SUCH PROPOSAL.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Continued and to be signed on the reverse side)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CHECK-CAP LTD.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">DECEMBER 22, 2016</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">GO GREEN</div>

<table id="z8810dd00c33e45799698b5a2d6ea1a6b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 25.65%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 48.95%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">material, statements and other eligible documents online, while reducing costs, clutter and</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">paper waste. Enroll today via www.amstock.com to enjoy online access.</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 26.03%">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Please sign, date and mail</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">your proxy card in the</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">envelope provided as soon</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">as possible.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; FONT-WEIGHT: bold">&#175;</font> Please detach along perforated line and mail in the envelope provided. <font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; FONT-WEIGHT: bold">&#175;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE ELECTION OF THE DIRECTORS NAMED IN ITEM 1 AND EACH OF THE OTHER ITEMS SET FORTH BELOW.&#160; PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.&#160; PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE &#9746;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7c78c6b1094741d592f64f1546f69130" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">To reelect five directors to serve as members of the Board of Directors of the Company, until the next annual general meeting of shareholders.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zf165b102a7574cc0be564ce7ce9950f6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.35%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AGAINST</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ABSTAIN</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Tomer Kariv</div>
</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 19.35%">&#9744;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">William (Bill) Densel</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.35%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 51.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -51.75pt">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Steven Hanley</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.35%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">XiangQian (XQ) Lin</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.35%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dr. Walter L. Robb</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.35%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.21%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze254f09c56194b41bb10f66e35779c01" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">To approve the compensation to be paid to each of the non-employee directors of the Company (other than the Chairman of the Board of Directors and the external directors), subject to their election at the Meeting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z3eabb814f770444eaa1b8b91705a5694" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AGAINST</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ABSTAIN</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1af63ff2470048dd805e49f9281e23d5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">To ratify and approve the reappointment of Brightman Almagor Zohar &amp; Co., a member firm of Deloitte Touche Tohmatsu, as the independent registered public accountants of the Company for the year ending December 31, 2016 and for such additional period until the next annual general meeting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z76928d35f3fe40cf856ffbdea9ce3520" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AGAINST</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ABSTAIN</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9bd7d589c08c4133b056a8b1b5dc5d08" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">To approve the payment to our Chief Executive Officer of the discretionary component of the pro-rated annual bonus for the year ended December 31, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z7ecf2a95a5e548ad86c66515cfc52df2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AGAINST</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ABSTAIN</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>
</table>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Do you have a &#8220;personal interest&#8221; (as defined in the Proxy Statement) with respect to the subject matter of Proposal 4? <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">(Please note: if you do not mark either &#8220;YES&#8221; or &#8220;NO&#8221; your shares will not be voted on Proposal 4)</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zed70df3463d34210bf22b3c156e9cb25" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.57%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.2%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">YES</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.17%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">NO</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.06%">&#160;</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.57%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.2%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.17%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.06%">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zdb6fa8b71ab64d018b0080c3b625e99b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">To approve the payment to our Chief Technology Officer (who served as a director until December 2015) of the discretionary component of the annual bonus for the year ended December 31, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z9ef1e01335674001853db622cb6a7799" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FOR</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AGAINST</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ABSTAIN</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.23%">&#160;</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.12%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.33%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; WIDTH: 19.32%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">To change the address on your account, please check the box at right and indicate your new address in the address space above.&#160; Please note that changes to the registered name(s) on the account may not be submitted via this method.&#160; &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Signature of Shareholder _______ Date _____ Signature of Shareholder__________ Date _____</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb7f56530923e427ab5fa8f7c5fa30dec" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 72pt; align: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Note</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">:</font></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such.&#160; If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such.&#160; If signer is a partnership, please sign in partnership name by authorized person.</div>
</td>
</tr>
</table>
</div>
</div>

<div>&#160;</div>

<div>
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) *L# 2(  A$! Q$!_\0
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MG/(]JS_AU<:/<^,M<DT*W:VMVLT^S1R?>7!^;N>^.]*-2:BYZ_H-PBVD12>
M/ MK.-,NO$;IJ7"G=,BX;_=Q@?0FL#3/!-A<:3XIN+BYG:;1W=(6C("OM!.6
M&#Z=C7&7J3QZA<1W:L+H2L)0_P![?GG/XUZA\,C!:^%/$IU.)_L\;J;B-A\V
MT(<@BM)\].'-S7V(CRRE:UCG-0\(V&B^ ;;5]2EN%U6](^SVZL H!Y!88SPO
M)^HKBZ].^+]G=37.F:M'*)M*DA$<.S[L;'G_ ,>&,?3%>8UM0DY0YF]R*J2E
M9!7I_P &/!HUW7VUF]CW6&G,"@8<23=0/HO7ZXKS*.-YI4BB4O([!44=22<
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MY5OP(%?(.H6%UI6HW%A>Q&*YMY#'(A[$?TK[6KSCXF?#./Q?#_:.G;(=9B7
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8** *\%E!;<QQC=_>/)JQ110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0C!W$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *2EHI, HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR-.BLW^T4]12?VFF>HI6"YIT54BNU?O5I3D9I#%HHHH **** "BBB@ HHHH
M**** "BBB@ HHI,T +132V*0/F@!]%,+XI0V: '44S?S2[N* '44P/F@OB@!
M]%-#9I<T +129HS0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUO%*$??_ %H7Q2@_C_6O$1K<^?O'\Z&UR<?Q'\Z/8] YSVUO%"9^_P#K3O\
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M=:S9)CFI))-U0%<F@"5/F%(PP:(SM%/(R* (Z*#P:* "BBB@ HI^WBF'K1<
MHHIP7-# ;1FG$8IM( HHHH ****8!0.#3]O%-QS1N I.14>*E9<"D5<T 1XJ
M:.3%,88IHZT 71/M'6E6].>M4R>*8.#0!M17&[O5V-LBL*&3%:$4_O0!HT5$
MCY%29H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *2EI*!,,TR60(N<TRXE$498FN4U7Q&L 8;
MNE7&-V)R-#4]8%JI.ZN*U7QD$##?^M8/B#Q0)0P#UYOJFJO(QPY_.NR%)'/*
M;9T.N^)?M);#]?>N$OIFFD+9J*2=W/)-)UKIC S;9!AB>M/!VT_;3'YK>*)O
M<>/GH(Q21<4\C-58G8CSS3PU-VTN,4R7J.)Q3=U!.:3;4IB2%W48[TFVG4+<
M89[4#BD I3S5I"%/-)G% XHZTP#'>C/:C/:C%" .E-)S3NM-(Q0-(<&P*0GF
MDQ10@%+<4*<&@KQ2 9I7'85FS0&XI",48S1<3#/-.+<4REQ2&*IP:&.:04$8
MH"XY6P*:3S0!24 .+<4*<4F*0#- D//S49P*!Q2$9IB$SS3]V1BH^]. Q2&*
M.*1CFEZTTC% T.5L"FD\T 4E #BW%"G%)B@4Q(5CFE#8%-(I0N12&)GFG%LB
MF=Z7'% "J<&ACFD S01B@!RM@4W/- '%&* '%N*13@T%<"D% "L<TH; II%*
M%R* $SS3BV13,<TN.* %4XH8YI ,T$8H <&P*;GF@#BDQ0 \MD4BG%!7 I!0
M K'- /%(1BC% F&>:<6R*92XH&*IQ0QS2"D- #U;C%'?-- IV>,4";!FXI%.
M*0BD H'<<QS2AL"FD8HQQ0%PSS3BV13*7% 7%4XH8Y-(!F@T!<<&XIN>:,<4
ME 7'LV12*<4A'% H"XK'- /%(:,4Q,,\TXMD4REQ2&*IQ0QR:0#-!H"XX-Q3
M<\T8HQS0%QS-D4BG%!7 I ,T *QR:4-Q331B@+AGFG%LBF4N* N*IQ0QR:0#
M-!H"XX-Q3<\T8I* N/9LBD4XI"* ,T!<5CDT!N*0T8IB8=Z4G(IM+C%  #B@
MG)H S2'B@!P;BD[T8HQS0 I.12 XI2N!2 9I!8"<FE#<4F*7;Q3"PG>E)R*;
MWI2,4  .*"<F@#-!&#2'8<&XIN>:,48YH"XYFR*13BD*X% &: %8Y- ;BD-&
M*8F)GFG9S3:<!B@&+]VFD\TX\TPB@$/#<8HQWIH'>G9XQ0#89S1G;28Q01FH
ME>P+<#)5NPMS<7"KCK5%4)E"^IKOO"N@-/-')MS7-49M&-SJ/!_AHK(DI3]*
M]ITZU$-N@QT%8WA[3%@MD^7FNI10J@5Y]6=SIA&PX4445@:A1110 4444 %%
M%% !1110 4UFP*4FJD\VT&@".XN, C-9$SY.:EGDW-5<C=0 Q6R:DIHCQS3J
M "GAN*924F IZT4#FG$8I@-H%*!F@C%*^H#MW%,/6B@<T[6 *<IQ2%<4E):@
M.8YIM%.V\4]@&T4&B@ H%*!F@C%*^H#MW%-+8.:2D(S3L OF;N*<IQ480BG4
M 2$;JC/%2*W%(5SS0!'2T44 )OVU-'/[U 4+4!2M &I%=XXS5Q+C(ZU@*2#5
MR.;CK0!LH^:EK-AF]ZNI)NH EHI!2T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 444AH #TJG<7:PJ23TIMW?I;J=
MQKB==\21HC@./SK6$')F;=B[KGB>*&%EWBO(M?\ $AED<*_ZUG^(_$$DLK!7
M_6N'N+N664DL:[*=&QBY7-.[U)Y6/S&LR1VD/6H\LU2(,=:Z(PL92D1@8IP-
M.84RMU&Q-R3.13"*5:5N:I(BY'4JM4>*44#)#36/%&>*::2)0B]:D%1BGBBP
M,=D"H\\TIR:9WI1*Z$F<B@<4U:<>:TN2-8TX'BF&@4AV'8YI2>*7M3"*!+45
M3S2MS3!3Q[TAM@.!3<_-2FF]Z8(E)!%-7@T@I32"X.>:%/%,.:!0#'8YI2>*
M.U--"8@4\TIYIHIZTP8#@4WO2D4WO0-(?G(I!Q2"G&@0C&E!XIAI10.PN.:4
MGBCM330(5#2MS3!3UI#; <"FXYS2GK2]J&Q >E(.*!UI3THN C'FG*1BHS2B
M@8I'-*3Q1VIIIBW%0XI6YI@IXI#; <"FYYI6IM,$2D@BF#@T"E:@&-8\T]2,
M5&:44@%(YI2>*.U(!S3$*O%#<T&@5([@.!30>:#24P1*2"*8.#0*4\TP8UC3
M@>*8:44!87'-*>E':FCK0(4<4'F@TJ\=:2 ,X%-SS2FF]Z8T/)R*0<4+2GF@
M0UC3@>*812B@=A<<TI/%':FF@0*:4\TT4]: 8 X%-[TIIM T//(I!Q0M*>:!
M#6/-.!XIAI0*!V%QS2L>*7M3"*!(%-*>::*>M ,,X%-!YH-)WH&B4D$4P<4"
ME:@&-8\TX'BF&E% 6%QS2L>*.U-- D"G!I3S313Q0##.!3>]!I.] T//(I!Q
M0*5N>E AK'FG \4PTHH&+CFACQ2]J8:!(53@TIY--%/% ,,X%-'6AJ2@:)&(
MQ35/-)S24@%;K3P1BHZ7F@8?Q4YCQ3**8AZ'!H;DTRGCI2!AG IHZT&D[TP1
M(2"*0<4@I3S0#&L>:<#Q3#2CK0%A<<TK'BE[4S!H$*IH/)IO2GJ: 89P*;GF
ME84V@:0YCQ2*PSBD-36UF\\B[1WK.<DBX(U=*TEKNX0@9YKW3P;H8BMT+)V]
M*Y+P3H)94+I7L^D6*P0@;<<5Y]:I8ZJ<2]:PB.( "K-(!@4M<+=S<****0!1
M110 4444 %%%% !114;N%% #)90HK)N9<DX-374V>AK.=B: &,^33TJ+:<YI
MXX% $K8(XJ,C%.0\TYAFIZ@1T48Q0.M4 ]1BACQ3NU1$'-3NP'(:&IN:*:5@
M"E7K2;:*-P)&/%1T9HQFC9  ZU)D8J/&*,T, /6BBC&*+@/4TC4W-%.P!2KU
MI-M'2DF!(Q&*CHS2XS3 0=:E!^6HL8HS0 'K1110!(A%-?&:;FB@!*4,12[:
M8_2@"Q'-[U>@N/>L9<@U9C8T ;T<H:I@<UDPS8ZFM"*4$4 3T4@.:6@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-(:04#L.84HQB@4AZTKB$[T_M2=J0'FBX#Z8?:E)I!0M@0HZ4W'-*>M+VHN
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MS2#80#BC/.*"<4N*0"@4N*8#2DX%)[B$/%*!D4@YHSBF,3'-.Q@4>])GM1<
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MH ,9I?:C.!3<\TK !%(!3\Y%(.*87%'%(1GFD8\TX'B@ SQBDQBC'-*3Q2L
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M9-<2+@9YKW/P-HX6)"RUY[X+T@S.A*U[MX>L!;Q*,8XKBKSL=%..IN6L(B0
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M;&![5+2#@4M>>SH"BBB@ HHHH **** "BBD)H 1CBLR[EQFK<TF.]9-S)DT
M57D)?%/(^3-1;?FS4P.5Q0! #\U2"E,>.:51F@!O>G!N*&%-I) !I*<.:<5Q
M0]P&@XH)S24#K3 2E'%/V\4P]:2 <6S3:*<HS0]@&BG;N*&&*;0@ TE.'-.*
MX%#W :#B@G-)0*8"4HXI^WBF'K20#BV:;13E7-#V :*=NXH88IM" #24X<TX
MKBA[@(#BD)S24"F E*.*?MXIAZTD XMFFT4Y5S0]@&BG;N*1ABDIH -)3@,T
MXKBD]P$!Q2$YI*!3 2G XIVWBF'K20#BV:;13E7-#V :*=NXI&&*2F@ TE.
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MCBD(S0(;GFG9S3>]. Q0-B]*:3DTX\TW%-"0Y6[4$=Z0"G9XQ4LJXWK3ONT
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MT4HGGUMX3D./D-;EIX8*@92O1X-.A4#*"K:V<0Z**P=0M1."3PYA?N?I2-H
MZ;/TKT$PQ!<8%0_9HRW05/M"XP.!_P"$=_V*HWGA@L#A*]1%M%C[HIK6D1ZJ
M*<:FI7(>)7?A1^?D-8-UX8D0D[37T!/ID+ _(*P;_1XV! 05JJ@G \%NM+:
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M\']P4#3H/[@K2-0' \1;PC(H^X:P=6T=K13E<8KZ%NM.@"9V"O,/&UO&B-M
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M&NJDC";T/*[HX<U7'-37)RYJ 5W15D8HD!H? %-)P*CR7.*<AJ-R_86[7#@
M9KTWPOHN0I9:YOP=I?VF1<K7LVDZ2MNB_+VKDG*QK&):TZP6&,<5J+\O%,4;
M!BEKAG.[-U$D/2F8S2[J0&LTRUH+]VD/-+29 I<HVP4<TYAQ2;U'>CS%/<4U
M%D.0BC)I6&*4.H[BD+ ]Z'%@F,-)C)I">:44E%C9*B@<UROBPYB;Z5U*FN5\
M5_ZIOI711W,F>'^(A^];ZUA(!MKH/$(_>-]:YW.!7I0>AA,EMS^^ KTCP6!Y
MZ_6O-;?_ %M>C^"F/VA?K6=1%0/:+89A7Z5,1BH;7_4K]*F->=59U1V%7K5/
M6/\ CR;Z5:!YJGK1_P!!;Z4J;U%(\3\5_?DKSX_ZP_6N_P#%!S))7!2##GZU
MZM)G),3O6EI=L9+E..]9Z#+BNQ\.V/F3(<456$#T/PQIH$2-MKO[>,)$!61H
M5F([13CM6V.!BO/J,Z(H#0#@TA-';-8+5FC&W;A;9CGM7E7BO4OOKNKO]8O!
M%;.,]J\4\37^^X<9[UV48V,I/0Y2^E,D['WJ!!0QW2$TI^45WHY6]1&ZTY0"
M*C)S3@U4A",.:2GD<9IH'-6B;BJ*1AS3CQ0.:! !Q29YH)Q3>] TAY'%(HH'
M-*>*!"'BEQD4PFE!H"P8YIQX%&.*:32#<4<TC#FD!IXYIAL '%)GF@G!Q1CO
M2 4CBD44 YH/%%P \4N,BD'-&><4 )CFG,.*,<4TFF&XY1DU)M%0@XIV^D4*
MP%1YYIV[-(PXXK.6@):DL<!E("C->N?#?2"S(76N \*6!O+E5*YYKZ!\):,+
M*-"%QQ7%6EH=,-&=A96BVZ  =JN4U>@IU>>SJ04444@"BBB@ HHHH ***8QQ
M0!#,^ :RIWY-7;A^M9<S_-0 QCFF;>:=11<!ZBD88I <4$YI6U 2E7FFTHXH
M D(&*C[TXMFFT+0 [U( ,5&*=NXH>H#3UHH-%.X#U&:1ABD!Q03FE;4!*5>:
M;2CBG>X$C 8J.G%LTVDM  =:DP,5&*=NXH>H#3UHH-%.X#U&:1ABD!Q03FE;
M4!*5>:;2CBG>X$C 8J.G%LTVDM  =:DP,5&*=NXH>H#3UHH-%.X#U&:1ABD!
MQ03FE;4!*5>:;2CBGN!(P%1TXMFFTEH #K4F!BHQ3MW%#U :>M%!HIW >HS2
M,,4@.*"<TK:@)2KS3:<.*>X#V J.G%LTVDM  =:DP,5&*=NXH>H"'K24&BG<
M!ZBD88H!Q2$YI6U 2E7FFTX'%/<![ 8J.G%LTVDM #O3]@Q3*=NHW :>M&<4
M&DIW M6[\UJP/D5A*^TUIVLF0*5M0-04M-0Y%.I@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4UCA33JAG;;$WTIH3=D<GXEU/R;>1=W:OG3Q7
M?&;4&Y[UZEX\U?R7D3=7B>J3>?=%\]Z[J,-+G/)D!Y&:11DT(<C%/QMYKN@<
MS \4PTK-FFUNMB10:=CO3*=G-*P@ZTO2C&*:3FFD _&132.:4-@4TFA;C'8Q
M2#F@GBD!P:0@(Q3@O%'6C.VID-$;\5-91^;*!4+\BM3P]!YUXHQWK&<C2*/0
M?!VE9=25KUJRMQ @X[5RWAG3O)C1L=J[/'RBO.K39TTUH!7=S0!@XH#8HSS7
M+>YJA6&!FHU.34F<C%1/B,9JXQ"XYW"CK5&>\5 ?FK*U;5Q;AOFKAM3\6;&(
MW_K73&G<S<CN)M9"MC=5<ZV!_%7E\_B@LV=_ZU7/B8GC=^M7[,ER['K4>N@G
M[U7X-45_XJ\77Q(5YW_K5VW\7;2/G_6FZ8N8]MBG5QG-6%8=C7E>G^+]Q4;_
M -:['3M8$Z@[JRE M2.G3@YK,UD[HC]*N6LPD YJMK"8A)]J459B;/#O&HP[
M5PHKO_&BY=J\^8X.*[:9B]R1.6KLO"*_Z6OUKCHNN:[+PD?]+7ZTJFHHGN&E
M?ZA/I6L>E9&EG$"?2M;.17!51UPV$QS4=V/W!J3/--NQ_HY-3#<)'F/B\?NG
M^E>0W0S.WUKUSQ>W[MQ7D=T<3M]:]*EL<LROC%+C(I,YHSCBNG9&3O8.]+MX
MHQWI<]JNY VD/%./%,)J&[EIZ$EH,W2_6O8O"0_=I^%>.V9_TI/K7L?A(?N4
M-<=30VBSTVU7]POTIYYJ.U;]P!4M<,V=,15&*I:K_P ><GTJ\*H:J?\ 0Y/I
M5T@F]#P7Q9_Q_/\ 4UR+C#5UOBP_Z<_U-<DQRV*[X'),C8UN:(<2I]:Q77%;
M6B#,J?6M)+043W3P@N;5?I75]*Y3PBV+5?I75D\5YM;<ZX"4N*8#S3\X%8I*
MY;,'5[S[/NYKC+WQ.89"-_ZUM^*9BH?FO']:OBLY&>];PB8MG>+XP/3?^M._
MX2TCG?\ K7EJWS==U/.H''WJZ53T(YCTX>,"?X_UI#XO/]_]:\O%\W]ZG?;6
M/>CV1+EJ>G?\):3SO_6@>+R#]_\ 6O,?MQ'>C[:>NZE[,.8],G\6ED^_^M<I
MK6KF[!^;.:YUK]B,;J@>X+=ZUIP(D]".;EC40%*S9I,X%=+V(B!Y%7M*L_M$
MP&.]9Z'<^*['PM9^9<+QWK*4K(VBCT#P9I A*';7I*H(U%8.AVH@C0X[5T)Y
M%>?6F;15AN,\TTTI;;Q3,Y-<+=V:+06G+0HS5>[F$"DYK6,=0;)99 G>L^>^
M5 ?FKGM5U\0[OF_6N-O_ !=AB-_ZUU1IW1G*6AWLVM!6(W5!_;H!^_7ETWB8
ML2=_ZU!_PD9)^]^M:JDC/F/7(]<#'[]:-OJ:R8^:O%E\2E/XOUJ_:^+MK#Y_
MUJ)4BHRN>W0NL@SFIQBO-=+\6>8 -_ZUU]AJ@G .ZL7!W*<C>Q@5R'BDYC;Z
M5U:2ATZURGBD8C;Z5K"-F0V>)^(FQ*WUKGU&170>(AF1OK7/@X%=<3*1);#]
M]BO2?!J8G4^]>:VQ_?5Z9X,.9T%9U7H.)[#:']ROTJP:AMEQ"OTJ8UYT]SKA
ML.5:H:S_ ,>C#VJ\K51UC_CT8^U$-R)'BGBI-KR&N /S2'ZUZ#XL/,E><.^V
M4_6O2@]#!JY=@CS,HQWKU;PCINY$;%>>Z):_:9$..]>T^%K/RK=>.U14EH.,
M=3K-/C\N +5MEQS44/RJ*D9LUQ3=V=,4,QFHYFV1FI16=J4_EQ-SVIP5Q2..
M\3:ELC==U>-ZQ=>9=MSWKLO%FJ8F9<]Z\\N7\R8M7=31A)C1US3_ +U1BG*<
M5U):'.]Q2M."\4=:"V!5(+B9[48QS3<\TN>*I$-"]:.E-!Q03FFPL.QD4SO3
M@>U+CO2#8,8%'WJ:30#B@+ 1BE XS2]:,XXH 3-!%&.]&<T@$ S2]*7I2=:+
M@+C/-)GM1G'%&.] "XQ2#FC.:.E !TI<9YHZTF<<4P#/:@BFYYIV<T "C-(P
MP:</EI2-W-2]BD(!Q4UM'YLNVJQ?!Q6SH%OYUXHQWK*>Q<8GH'@31\7"-M[U
M[M86HBA3CM7 ^$-,\I8VVUZ9$,1K]*\NM)W.N$1P%+117.:A1110 4444 %%
M%% !4,IP*E-4+R;90!4NI<&J+'<<TZ5]YI@XHL 4M%%) % ZT4"G<!^WBF'K
M3]W%,/6D@"G*,TVG*<4/4 88IM.8YIF:>P#AS3BN*:O%.+9%)@,H'6B@4[@/
MV\4P]:?NXIAZTD 4Y1FFTY3BAZ@##%-IS'-,S3V <.:<5P*:O%.+9%)@,H%%
M IW ?MXIAZT_=Q3#UI( IRKFFTY3BAZ@##%-IS'-,S3V <.:<5Q35XIQ;-)@
M,H%% IW ?MXIAZT_=Q3#20!3E7--IRG%#U 1ABDIS'-,S3V <!FG%<4U>*<6
MS2>X#*!10*=P'[>*8>M/W<4PTD 4Y5S3:<IQ0]0$88I*<QS3,T]@' 9IQ7%-
M4XIQ;(I=0&4#K10*=P'[>*8>M/W<4PTD 4X+FFTX'%#U 0C!I^WBF$Y-+NXH
MV 0#FG%<4W/-*6S2Z@,[U;MY-I JI3XVPXJK@=# V4J:JMHWR5:H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)U2[$,3\]JU3TKBO%E[Y"/S
MCBK@KLB>QXW\0+LR73X/>O.&^9JZOQ9=^=<-SWKE >:]6G%6.23'JN.:5FI<
M\4PBNF*L9-B4N*2G@\5H]A,;WI0,48YS2YXJ1!G--(Q2CBE/-" :!FC'-.!P
M*;GFBXT*5XIH%29R*:.#2!BCBD(SS0QI0W%*6P(8J[GVUV7A#3B;Q6QWKD[-
M?,NE'O7K'A'3]K(VVN2I(VB>DZ7;^7;IQVK2;BH[8!8%'M3F.:\^J[LZ(!MS
M1TIRFAQQFLXK4NY#)+Y8S7/ZOK8@0_-5G6+X00DY[5Y9XBUO>7 >NJG SDPU
M_P 1>86 >N#OKMIG)#5'>7+2L?F-5!D]:[(0,I,7<Q[TF&'.:>!3F(Q6G(9\
MQ'ECWI/G4]33UX-.(S1R: I%RRNVB=3NKM-(\2>5M4O^M>>Y*U)!,Z2 Y-92
MIHI3/?-%\0K(5&ZMO4;X30=>U>):-K)@=<O78#Q&KQ ;^U1[+4KFT.<\9/\
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MNXIAHI0,TP$IRG%!7%-I+4!6.:;FEIVWBA@(IQ3BV13#13L 4"E"YH(Q2OJ
M[=Q3#12@9I@)3E.*"N*;26H"L<TW-**=MXH8"*<4XMD4PT4[ % I0N:",4KZ
M@.W<4T-@YI*3K3V TK*7)K64\5B68VM6Q&V10!+1110 4444 %%%% !1110
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MQYIS>U1F@5AX/%)WI!3NU,0$\4(:::04#0]Z!TH'O2'K2L(3O3CTH[4@ZT(
M7WH)YI3[4RF-$H/RTP]:09HI%6''I2"@4&D0(>M.R-M1FCFI;*1:TY/,N@/>
MO9O ]@%>,XKR?P];F2]48[U[]X1L#&D;8KBKRL=4(H]!M(PL2_2K5,B7$8^E
M/KSF[LZ$K!1112&%%%% !1110 5%*V!4AJM.V!30&9>O5%3DU/=MN/%5T!%-
MH"P,;:C/6C-)4@*:<E,HZ5-KC8]NM Z4RBFQ6%[TIZ4VC- K#A2'K244GN,D
M&-M,/6D%.H0T(:!28HJD%QQIN:7M49SFKZ!N2+UI[8Q48Z49K-[B%%'>DHHO
MJ.^A*"-M1]Z,FDIB'-TIHHHJ06@IHR*!TIASFFM2QXI32#I24TR7H.6D/6DH
MJ1$@QMIAZTF:*: 6E%(*#3* TE%&*&R15I6Z4VC-2PL.6D/6DHHL \=*;WI*
M*=K"L.:E2F49Q2M<>PYNM*.E,SFCFFP'#K3FZ5'1FBP"B@TE%4,=VI!244F)
MCC0IIM(<TN@K:#SUI>U(O2D.:5Q+45>M.;&*CHS5%!0.M&**5P).,5&>M&:*
M+6 *>M,QBC.*-P'/3:,YHQ1L JT]NE1]*,T6 *!UHQ11<"3M4;=:,T&G8!4Z
MUK6)X%9*UJ69Z4 :@HIJ]*=0 4444 %%%% !1110 4444 %)2TE ,R]=.W3W
M/M7SIXPGS<R#-?0WB-MNF2'VKYD\5W!.H2#/>NS#&-0Y0\RFGL!4>?F)IV<U
MZ4#DD.4<4F>:3-'>M=R"0@;:8!S1FDS3M8!S<4#I2#F@G%3U$&.:4CBCM29Y
MJFP 4II#Q2CFD@ =*:3S2GBFT,$/%+P:9FC<:E(+ 0!3EQ32<U&6(--E)&]H
M,^V_3GO7O?AZX#6<?/:OG729-ETK>]>S^%=0WHBYKAKJYT0/1U^9:8XQ1&W[
MI3[4UCFO-DK.QNF2)TJ*\0/"5IP;%#?,,4X: SS'Q9I>8G8+7DEW:M'.V1WK
MZ+URP$T#<=J\B\1Z086<JM=M.9C*)PS'%2+@BHYHG5CD&FJQ KMA(R:L./WJ
MD &*BSS2[^*OF)L28%,:F[Z4<TKV$*,8YIIZTQB<X%3V\#R,/E-)S*41$A9S
MP*NP:;*W\)K<T;1VF<90_E7=6OAI!&"4'2L^87*>47-H\/455P,<UW?B;3$M
MMV *X&Y;8^!5)IC2&C[]=;X4_P"/I?K7(1G)KL/"7-XOUK.IL7$]QT7F%,^E
M;;\"L72!M@3Z5L$Y%>966ITP&]34=T/W)I_>FW7_ ![FIIK4IGF7C$#R7^E>
M.77_ !\-]:]B\7G,3UX_=C]^WUKTZ2T.>;( *=CBA13C79%:'/S:C0.:<5&*
M;2YS2E$5Q%&32L,4O2FDY%1;0<=0M?\ C[7ZU[)X0'[I/PKQFV/^EK]:]E\(
M?ZE*QJ;&Z1Z?; >0/I4BCFH;4YA6INE>946INMAS<53U( V4GTJUG-4]3/\
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M3K78>$3_ *8OUJJFPXGNFD#,"?2M9Q@5DZ2<0)]*UF.17FU5J=,!@'-,N_\
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MDHI: %QQ3:=FDH86 TY1FF9IRMBD@8,,&C'%(3FESQ3)8@'-*12 \TI.: $
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MF.:$ HYI3Q1C%*.:0AHYH)YI6XHQD9I( [4TTHZTYEXH&D1@T\<TT"E/%,3
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M>)[82H^17B/B6$13D#UKWOQ F8V^E>%^+ABX;ZUZ%*1S2W.:3I3P:CCZ5+C
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M;5F9L0BFCK2DT@.*H.@K#% %+UI#Q0 9YQ2D<4S/-.!S0%A .:<>*,8II.:
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M6@K]JAN1N2NFFR)+0\7\967E*Y KS;;ES7LWC>VS$W%>/W*>5(WUKT*3.:1
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ML>373&!FV7;B\>0GYC5/<V<DT@)[U(%W]*U2);(V:GHW%2"T8TQXS&>:M$M
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MA&!3 GHHHH **** "BBB@ HHHH **** "BBB@!#TKG_$46^T8>U=#69J\6^
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M !7GW@&VS8H<=J]'A7:F*\JMN=E-$E%%%8F@4444 %%%% !37^Z:=4<I^4T
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M2 4#'#FD)Q2]*,9H$,SS3@<TW'-.QCF@;%/%,)I_WJ:1B@2 &G8XS2 4N>U
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M<TH--(I0*!BX[T$\4N>,4TB@0 XIW6F 4\<4 PS@4S/-./--QS0-#\Y%'2D
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MI1EH<DXZE7<",4 8-1)G=4YZ5V)F,D,;FE' H'%(:+ZD"9YJ3((J.E&:;10
M8-#&E-,(H$M1ZGBDQSFFBG]J$Q,#TI!Q1WI32OJ AYI1P*04&BX"9YJ0D8J*
MEYI]2A1UH8TE)38K#U/%)CFFBI.U(0A/%-4\T&DH'8<W-*.!0M(U A,\T[J*
M9WI5H&T*!@T,:4TPT"0]3Q28YIHJ3M0 A/%-4\T&DH'8<W-*.!0M(U A,\T[
MJ*9WI5H&Q1P:&-*W2F&@2'@\4F.::*D[4 (3Q35/-!I!0.PX\THX%"TC4"$S
MS3NHIG>E6@;%'%#&E:F&@2'@\4F.:04_M0 A/%-4\T&D% [#CS2C@4+2-0(3
M/-./(IE*M V*.*&-*U,- D/!XI,<T@I_:@!">*:IYH-(*!V''FE' H6D:@0F
M>:<>14=.6@;%'%#&E:F&@2'@\4F.:04[^&@ )XIJGF@T@H'8<>:4<"A:1J!"
M9YIQY%,I10-H4<4C&G-3#0)#P>*3'-(*=_#0 $\4U30:04#L./-*.!0M(U A
M,\TX\BF4Y:!L!Q2,:<U,- D/!XI,<T@IW\-  3Q35-!I!0.PX\THX%"TTT"#
M/-.)R*93EH&P'%(QYIS>U,- D/!XI,<T@IW:@ )XH0TTT@I#0]N:!P*![TUJ
M8MPSS3B<BHZ>M V XI&ZTYO:F4"0\'BF]Z2B@:'>84Y!KT/P%JIAE3<W>O.6
M!K:T*\-M*O..:YZL=#6#/JG0[X7,2D'/%;N:\Q\$ZPKQ(&:O2()A*N17DU(V
M9UPEH3T445D:!1110 4444 %%%% %:\A5[=P1VKQ#QQI&Z61PM>ZR#*$>U<)
MXJTP2V\C;:Z*$K,B:NCYEOXC%<%:K=JWO$=F8KY^.]8&<-BO1C*Z.68Y%_>+
M]:]R^&T8,*<=J\4MX_,D7'K7NWPW@*PIQVK"HP@>LV@P@JU4%N,(*GKSY;G9
M'8****D84444 %%%% ",>*P]08[ZVGZ5AWWWJ5]0(%/RTSO2 \4M%@''I2H:
M9138QS=:<",5'1S28A>]*<8IM+0(0G%+G*U&V33DX'-:P!F'KMN)+5^.U>&>
M([ I=.V.,U]!:A#YD+"O+?%>EX1VVUTPEJ921Y0#M?%3!ABHKJ,QW##WI@8U
MW0D<LEJ2L,FC.T4J]*8X-:$EW3KQXIP=QKT+1O$&Q5!?]:\N4E3D5<@O98^C
M5A4B6F>]6'B6+ RPK;AUZ)Q]X5X#:ZS*I'SFN@L]?=0,O^M<[IZEJ1[-_;,6
M.HIIUJ(?Q"O+!XB./O\ ZU$_B$G^/]::@6WH>IR:_"H^\*QM0\2Q 'YA^=>;
MW&OOCAZP;[6IGSAZKD)YM#LM7\0A]VU_UKC9M5>2Z^^>M8\E]*X.6-5K>1FN
MAD]Z?(5%GJOA69WG0DGK7LFGL/LR_2O&?"(RZ5[#8Y%NOTK&HK,$</X^Y1Z\
M1U+B4_6O<?&L9D1L5XCK4924_6M*1G-%!2"*:5IL9J8X*UVI:&6Q&IPU>H>
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MUQH]H+5Z!8^((C"-S]J\'@O7AZ$U=3Q%/'P&/YUR3A<UC+4]EU'Q!&(CM?\
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MI :HFPYA2@<4#FD)Q3 ,\XI2.*93@<T@$ R:<>*",4PF@-QXYIN.: :=CC-
M;!C I <FD)I : L*PQ2J*4<TA.* #/.*4CBF9YIP.: L(!DTX\4'BF$T!N/'
M--QS0#3L<9H#8,8%(.:0FD!H"PK#%*HI1S2$XH ,\XI2.*9WIP.: L(HR:<>
M*#Q3": W'XR*;CF@&G8XS0&P8P*0<TA-(#0%A6%*!Q2CFD)Q0 9YQ2D<4S/-
M.!S0%A%%./%!XIA- ;CP,BFXYH!IV.,T!L&,"D'-(32 T!85A2@<4HYI"<4
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MU1LTZ5J(,"@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[49Q3,\T!N.([T@&:=G(HZ4 '2C&::3FE!XH ;CFG8QS1CO03QB@!?O4TC%
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MY=QG;WKU708MD8^E8=II'ER9V]ZZK3X?+4"KF]"4M31HHHK$T"BBB@ HHHH
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MA]T?E67-HJN>$%=4VTBA$3N*T52Q/*<@FB*I^Y6E;:8B#[H_*MQXTSP!2;5
MZ52JC42M';HH^Z*F"*O04O>@]*S<QI"-[4H Q@TE'>IYQ]"O/9I("=HK(NM)
M5\X0?E72 C;3"BD]*U50BQR,.B*KYV?I6M;Z:BX^4?E6OY:>@IP4"E*8*)6B
MMT3^$5.$ '2@T[/%9.0VAHZT[&!31UJ0G*TXO4#A_%?W'KQ/Q!_KS]:]K\6\
M(]>*:_S,?K7HTM48S,9!Q2D4)TJ3'%==M#$FLQAQ7K'@E0VRO*;0Y<?6O5_
MYP$K";"*U/4((T\OD#I4,MHC-G:*F@.5%2\5Q2EJ=$8F>;&,C[H_*D6PC!^Z
M/RK2 %*<5FIE\I1%E'_='Y5(MJ@_A%61@4N10YZ%*)&L2KV%.8#'%*:;4.8[
M"1C::>QS3:!47"P"EHHI% .:<5Q2+P:<QXJ;Z@,HI12=Z&/H+MH YIX/RTW.
M&IH0%<"FT\N"*93 *0TM(>>* %B^=L5KVD&W!JA9PGS :W8U 44A(>.E+113
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI<\XI6'% D,%/'/6FJ.:4\4 P--[T_&13<<T#0HI3QTH(P*0<T"&FE%##FG
M<4#N':FFESSBE8<4"0P4\<]::HI3Q0#$-)WI^,BFXYH&A12MQTH(P*0<T"%%
M!-!XHZBF@&T8H'6GL.*F6J+3.A\.WIMY%P<<U[[X*U 30KENU?-%E.8Y!S7L
M_@35-J("U>=7A<Z(,]K5@W2GU0T^?SH@<U?KSVK,Z4%%%%(84444 %%%% !1
M110 4444 %%%% !1110 AJK<'BK55+OA:3&94YY-5LYJ:0Y-18YI)6"V@4=*
MD"\5&>M-"%W4E%/44]@&4NZE84V@!:3FE7DT]AQ3; CHHH[T@"BI .*9WI7
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MZ: ,TE.(I5&:'L"&4 TYA@T <4@8IZ4SFG Y-*PP*0)#,XHSFBBJ0"4M%%"
M*0DTM*JY-,3'11%F!K:M4P@JM:P9 K11-HH&/'2EHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HIDWQ,
MOJ*EI",B@1YUXJT$2PN^VO"=?TXP7+_+7U3JEJ)[9EQUKQWQ=X<P'D"_I7=0
MF82C9GB+,48BI$.ZKNH61BF88Z&J2#;7H0,9(<>*3%.(S335MF+0F><4[I2
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MD I<]J &DT@-.(I ,T#'#FD)Q2]*,9% AF>:<#FFXYIV,4#8IXIA-/ZTTC%
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M4#T%QWH)[4N>,4TB@0 X-.ZTP"GCB@;#.*9GFG$9IN.: 0[.1BEZ4@&*4G-
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M-H%'4!V[BD!YHVTAH06'EN*;FDI0,T]@$IV:0C%)0.X44#FG%:! IQ033:*
ML.SQ2#K2[>*::5K@/+9%,S12@9H>B 3/-/W<4TC%-I= %/6BE'-*5J@%4XI&
M.:;0*: 3-*O%.VTWI4[L!Y;(IE%*!FGL E/W<4TC%)BD]0#OFC-'6EVXI#N
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MT[ '>@=:,9HQBE?4"0'BHSUHS11:P!3U-,Q1FC<!S4VBC%&P"K3R>*CHS3L
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MLC%24F &:&&*13BG'YJ N- [T-R,4N<#%,SS0T@3U+NG-Y$H;WKVKX?ZAO*
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MQ6R:LQK28$:IS5ZWM<X.*=%;[B#BM&*/:N*$ D<6T5*!BG44P"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AFB5T((
MJ:BA,&<7KFB+<(V$ZUY9KOA%@S-L_2OH&2%7'(K"U72HYHSA!^5=-.J83@?+
MVH:*UNS?+6+)&4->YZ]X6,FXJGZ5YSJOAJ2 L=IKOA431@XLY 4E6KBW,!P1
M50GFM5,SL.%+MIJMS4@85I=,EW&[:7;3MPHR*JPKL3--(HSS3LY%(!@%+BE
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M)H0<]J^9/">H&"2,;N]?0GA6Z$UFISVKRJZ.JF=/12 YI:Y38**** "BBB@
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MGL !2 CSBC.:*.],!,4O2I0!BHCUI +G-)13T -,!E+NI7X--H *,4J]:>P
M%(".BG+2'K0V%QN*6I !MIG>D@$HIS4)S1<$-HYIS<&G#&*&!&:3FG#K3B!B
MF*PSI124O>BPPI&/%28XIFW)HL*Y&K'-24XQXH1#Z4QC=I- C8GI5J.')Z5>
MBM01TH SXX3Z5<AM\]15Q;8#M4BQ@4TP&) !4RKBE I:0!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDYS5GR/:CR?:A("MDF@$BK/D>U'D>U%@*Q)-,+G.*N>1[4GV7OBG8"NI/6G
MDU86W]JE%M[4- 46!IR*35\6N[M4R6?M0@1G!3TJ41=\5>%ISTJ46_'2@"C'
M#N/2K M0.U64AVFI=M %>. "K"K@4X#%+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:Q1BG<"H(.>E2>54^*6BX$*QXJ4"EHI &**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ,4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
